<SEC-DOCUMENT>0001144204-11-071774.txt : 20111228
<SEC-HEADER>0001144204-11-071774.hdr.sgml : 20111228
<ACCEPTANCE-DATETIME>20111227173458
ACCESSION NUMBER:		0001144204-11-071774
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20111228
DATE AS OF CHANGE:		20111227
EFFECTIVENESS DATE:		20111228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Dehaier Medical Systems Ltd
		CENTRAL INDEX KEY:			0001474627
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-178771
		FILM NUMBER:		111282734

	BUSINESS ADDRESS:	
		STREET 1:		SUITE 501, JIUZHOU PLAZA
		STREET 2:		83 FUXING ROAD,
		CITY:			HAIDIAN DISTRICT, BEIJING
		STATE:			F4
		ZIP:			100856
		BUSINESS PHONE:		(8610) 5166-0080

	MAIL ADDRESS:	
		STREET 1:		SUITE 501, JIUZHOU PLAZA
		STREET 2:		83 FUXING ROAD,
		CITY:			HAIDIAN DISTRICT, BEIJING
		STATE:			F4
		ZIP:			100856
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>v244049_s8.htm
<TEXT>
<html>
<head>
    <title>Unassociated Document</title>
    <!--Licensed to: Vintage Filings-->
    <!--Document Created using EDGARizerAgent 5.3.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As filed with the Securities and Exchange Commission on December 27, 2011</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Registration No. 333-<font style="DISPLAY: inline; TEXT-DECORATION: underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">UNITED STATES</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Washington, D.C. 20549</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div>
<hr style="COLOR: black" align="center" noshade size="1" width="20%">
</div>

<div>&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">FORM S-8</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">REGISTRATION STATEMENT</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">UNDER</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">THE SECURITIES ACT OF 1933</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div>
<hr style="COLOR: black" align="center" noshade size="1" width="20%">
</div>

<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Dehaier Medical Systems Limited</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Exact name of registrant as specified in its charter)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">British Virgin Islands</font></div>
</td>
<td valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Not applicable</font></div>
</td>
</tr><tr>
<td valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(State or other jurisdiction of</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">incorporation or organization)</font></div>
</td>
<td valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(I.R.S. Employer</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Identification No.)</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Suite 501, Jiuzhou Plaza</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">83 Fuxing Road, Haidian District</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Beijing 100856 China</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">+86 (10) 5166-0080</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;(Address of Principal Executive Offices) (ZIP Code)</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">
<div>
<hr style="COLOR: black" align="center" noshade size="1" width="20%">
</div>

<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dehaier Medical Systems Limited 2009 Share Incentive Plan</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Full title of the plan)</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">
<div>
<hr style="COLOR: black" align="center" noshade size="1" width="20%">
</div>

<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">With copies to:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Bradley&#160;A.&#160;Haneberg,&#160;Esq.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Anthony W. Basch,&#160;Esq.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Kaufman&#160;&amp;&#160;Canoles,&#160;P.C.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Two James Center</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1021 East Cary Street, Suite 1400</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Richmond, Virginia 23219</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">(804)&#160;771-5700</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Name and address of agent for service) (Telephone number, including area code, of agent for service)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="45%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Large accelerated filer</font></div>
</td>
<td align="left" valign="top" width="5%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font></div>
</td>
<td align="left" valign="top" width="45%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accelerated filer</font></div>
</td>
<td align="left" valign="top" width="5%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="45%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Non-accelerated filer (Do not check if a smaller reporting company)</font></div>
</td>
<td align="left" valign="top" width="5%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font></div>
</td>
<td align="left" valign="top" width="45%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Smaller reporting company</font></div>
</td>
<td align="left" valign="top" width="5%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font></font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Calculation of Registration Fee</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="27%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 1.05pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title&#160;of&#160;securities&#160;to&#160;be</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 1.05pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">registered</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="bottom" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 1.05pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amount&#160;to&#160;be</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 1.05pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">registered<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)(2)</font></font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="bottom" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Proposed&#160;maximum</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 1.05pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">offering&#160;price&#160;per&#160;share<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(3)</font></font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="bottom" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 1.05pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Proposed&#160;maximum</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 1.05pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">aggregate&#160;offering&#160;price<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(4)</font></font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="bottom" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 1.05pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amount&#160;of</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 1.05pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">registration&#160;fee<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(4)</font></font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="27%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common shares, par value $0.002731 per share</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 1.05pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">450,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="bottom" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 1.05pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.63</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="2%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="bottom" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 1.05pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">733,500</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="bottom" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 1.05pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">84.06</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(5)</font></font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="3%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div>
</td>
<td align="left" valign="top" width="75%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this Registration Statement includes an indeterminate number of additional shares which may be issuable in accordance with the 2009 Share Incentive Plan (the &#8220;Plan&#8221;) to prevent dilution from stock splits, stock dividends or similar transactions.</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>
</td>
<td align="left" valign="top" width="75%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The 450,000 shares registered hereby represent common shares issuable pursuant to the Plan, either directly or upon exercise of options or warrants issued under the Plan.&#160;</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(3)</font></font></div>
</td>
<td align="left" valign="top" width="75%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(h) and 457(c) under the Securities Act based on the average of the high and low prices reported for the Registrant&#8217;s common shares on the NASDAQ Capital Market on December 22, 2011, which were $1.76 and $1.50, respectively.</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(4)</font></font></div>
</td>
<td align="left" valign="top" width="75%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Determined in accordance with Rule 457(h).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(5)</font></font></div>
</td>
<td align="left" valign="top" width="75%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Paid herewith.</font></div>
</td>
</tr></table>
</div>



<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EXPLANATORY NOTE</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Dehaier Medical Systems Limited (the &#8220;Registrant&#8221;) has prepared this Registration Statement in accordance with the requirements of Form&#160;S-8 under the Securities Act to register its common shares,</font> <font style="DISPLAY: inline; FONT-SIZE: 10pt">par value $0.002731 per share, issuable pursuant to the Plan.&#160; The Registrant&#8217;s stockholders approved the Plan on November&#160;20, 2009.&#160; This Registration Statement is being filed in order to register the Registrant&#8217;s common shares that may be offered or sold to participants under the Plan, either directly or upon exercise of options or warrants issued under the Plan.</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PART&#160;I</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">INFORMATION REQUIRED IN THE SECTION&#160;10(a)&#160;PROSPECTUS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Item&#160;1.&#160; <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Plan Information.</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The documents containing the information specified in this Item&#160;1 will be sent or given to employees, officers, directors or others as specified by Rule 428(b)(1) under the Securities Act.&#160;&#160;In accordance with the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;) and the instructions to Form&#160;S-8, such documents are not being filed with the SEC either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule&#160;424 under the Securities Act.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Item&#160;2.&#160; <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Registration Information and Employee Plan Annual Information.</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The documents containing the information specified in this Item&#160;2 will be sent or given to employees, officers, directors or others as specified by Rule 428(b)(1) under the Securities Act.&#160;&#160;In accordance with the rules and regulations of the SEC and the instructions to Form&#160;S-8, such documents are not being filed with the SEC either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act.&#160;&#160;Such documents, together with the documents incorporated by reference herein pursuant to Item&#160;3 of Part&#160;II of this Registration Statement on Form&#160;S-8, constitute a prospectus that meets the requirements of Section&#160;10(a) of the Securities Act, and are available upon written request to: Secretary, Dehaier Medical Systems Limited, Suite 501, Jiuzhou Plaza, 83 Fuxing Road, Haidian District, Beijing 100856 China, +86 (10) 5166-0080.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PART II</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Item&#160;3.&#160; </font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Incorporation of Documents by Reference.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following documents are incorporated herein by reference:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)</font></div>
</td>
<td align="left" valign="top" width="72%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Registrant&#8217;s annual report on Form 10-K for the fiscal year ended December 31, 2010, filed with the SEC on March 7, 2011;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2)</font></div>
</td>
<td align="left" valign="top" width="72%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Registrant&#8217;s quarterly reports on Form 10-Q for the quarters ended March 31, 2011, June 30, 2011 and September 30, 2011, filed with the SEC on May 3, 2011, August 11, 2011 and November 10, 2011, respectively;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(3)</font></div>
</td>
<td align="left" valign="top" width="72%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Registrant&#8217;s current reports on Form 8-K, filed with the SEC on July 15, 2011, August 31, 2011, September 30, 2011 and November 28, 2011; and</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(4)</font></div>
</td>
<td align="left" valign="top" width="72%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The description of the common shares, $0.002731 par value per share, contained in the Registrant&#8217;s registration statement on Form S-1 filed with the SEC November 12, 2009 (File Number 333-163041) and declared effective by the SEC on March 26, 2010, and any amendment or report filed with the SEC for purposes of updating such description.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div>&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All documents that we file with the SEC pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement (that indicates that all securities offered have been sold or that deregisters all securities then remaining unsold) shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing of such documents.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Item 4.&#160; </font><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Description of Securities.</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Not applicable.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Item 5.&#160; <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Interests of Named Experts and Counsel.</font></font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Not applicable.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Item 6.&#160; </font><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indemnification of Directors and Officers.</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">British Virgin Islands law does not limit the extent to which a company&#8217;s articles of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the British Virgin Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime.&#160;&#160;Under the memorandum and articles of association of the Registrant, the Registrant may indemnify its directors, officers and liquidators against all expenses, including legal fees, and against all judgments, fines and amounts paid in settlement and reasonably incurred in connection with civil, criminal, administrative or investigative proceedings to which they are party or are threatened to be made a party by reason of their acting as our director, officer or liquidator.&#160;&#160;To be entitled to indemnification, these persons must have acted honestly and in good faith with a view to the best interest of the Registrant and, in the case of criminal proceedings, they must have had no reasonable cause to believe their conduct was unlawful.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers or persons controlling the Registrant pursuant to the foregoing provisions, the Registrant has been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Item 7.&#160; </font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Exemption from Registration Claimed.</font></div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Not applicable.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Item 8.&#160; </font><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Exhibits.</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Exhibit Index is hereby incorporated by reference.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Item 9.&#160; <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Undertakings.</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) The undersigned Registrant hereby undertakes:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in the volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of a prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement; and</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div>&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial&#160;<font style="DISPLAY: inline; FONT-STYLE: italic">bona fide</font>&#160;offering thereof.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) That, for the purposes of determining liability under the Securities Act of 1933, each filing of the Registrant&#8217;s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be in the initial bona fide offering thereof.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SIGNATURES</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing this Registration Statement on Form S-8 and has duly caused it to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Beijing, China on December 27, 2011.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" colspan="2" valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dehaier Medical Systems Limited</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="45%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:</font></div>
</td>
<td align="left" valign="top" width="45%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/&#160;Ping Chen</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name:</font></div>
</td>
<td align="left" valign="top" width="45%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ping Chen</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title:</font></div>
</td>
<td align="left" valign="top" width="45%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Executive Officer</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="45%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Principal Executive Officer)</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="45%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:</font></div>
</td>
<td align="left" valign="top" width="45%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/&#160;Yanying (Aileen) Qi</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name:</font></div>
</td>
<td align="left" valign="top" width="45%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Yanying (Aileen) Qi</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title:</font></div>
</td>
<td align="left" valign="top" width="45%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Financial Officer</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="45%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Principal Accounting and Financial Officer)</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Signature-1</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Power of Attorney</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Ping Chen, his or her true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any or all amendments to this Registration Statement and any and all related registration statements and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to the requirements of the Securities Act of 1933, the following persons in the capacities and on the dates indicated have signed this Registration Statement on Form S-8.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">SIGNATURE</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">TITLE</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">DATE</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/ Ping Chen</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Executive Officer and Director</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 27, 2011</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ping Chen</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Principal Executive Officer)</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/ Yanying (Aileen) Qi</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Financial Officer</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 27, 2011</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Yanying (Aileen) Qi</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Principal Accounting and Financial Officer)</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/&#160;Phil Fan</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 27, 2011</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phil Fan</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Authorized Representative in the United States)</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/ Peter Zhuo</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 27, 2011</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Peter Zhuo</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/ Genhui Chen</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 27, 2011</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Genhui Chen</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/ Weibing Yang</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 27, 2011</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weibing Yang</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Signature-2</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EXHIBIT INDEX</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 2.25pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: underline">Exhibit&#160;Number</font></div>
</td>
<td align="left" colspan="2" valign="top" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Description&#160;of&#160;Exhibit</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" colspan="2" valign="top" width="88%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.1</font></div>
</td>
<td align="left" colspan="2" valign="top" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Specimen Share Certificate<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.1</font></div>
</td>
<td align="left" colspan="2" valign="top" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Opinion of Kaufman &amp; Canoles, P.C., British Virgin Islands Counsel<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>
</td>
</tr><tr>
<td align="left" colspan="2" valign="top" width="100%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23.1</font></div>
</td>
<td align="left" valign="top" width="66%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Consent of Friedman LLP<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"> (2)</font></font></div>
</td>
</tr><tr>
<td align="left" colspan="2" valign="top" width="100%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23.2</font></div>
</td>
<td align="left" valign="top" width="66%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Consent of Kaufman &amp; Canoles, P.C., British Virgin Islands Counsel (contained in Exhibit 5.1)<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">24.1</font></div>
</td>
<td align="left" colspan="2" valign="top" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Powers of Attorney (included in Part II of this Registration Statement)<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">99.1</font></div>
</td>
<td align="left" colspan="2" valign="top" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dehaier Medical Systems Ltd 2009 Share Incentive Plan<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">

<div>&#160;</div>

<div>
<hr style="COLOR: black" align="left" noshade size="1" width="20%">
</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="6%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div>
</td>
<td align="left" valign="top" width="72%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Incorporated by reference to the Company&#8217;s registration statement on Form S-1, file No. 333-163041, filed on November 12, 2009, as amended.</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="6%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>
</td>
<td align="left" valign="top" width="72%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Filed herewith.</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: no; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Exhibit-1</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>v244049_ex5-1.htm
<TEXT>
<html>
<head>
    <title>Unassociated Document</title>
    <!--Licensed to: Vintage Filings-->
    <!--Document Created using EDGARizerAgent 5.3.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="70%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><img src="logo.jpg"></font></td>
<td width="30%">

<div style="DISPLAY: block; TEXT-INDENT: 0pt">

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Kaufman &amp; Canoles, P.C.</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Two James Center</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1021 East Cary Street, Suite 1400</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Richmond, VA 23219</font><br>
</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Mailing Address</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Post Office Box 27828</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Richmond, VA 23261</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">T (804) 771.5700</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F (804) 771.5777</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">kaufCAN.com</font></font></div>
</div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">December 27, 2011</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dehaier Medical Systems Limited</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1223 Epoch Center</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No.31 Zi Zhu Yuan Road</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Haidian District</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Beijing 100089</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">People&#8217;s Republic of China</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Re: Dehaier Medical Systems Limited Form S-8</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dear Sir:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We are British Virgin Islands counsel for Dehaier Medical Systems Limited, a British Virgin Islands corporation (the &#8220;Company&#8221;), in connection with the registration and offering of a number of the Company&#8217;s common shares, US$0.002731 par value per share (the &#8220;Common Shares&#8221;) in an aggregate dollar amount of US$733,500 offered for sale under the Securities Act of 1933, as amended, through a Registration Statement on Form S-8 (&#8220;Registration Statement&#8221;) as to which this opinion is a part, to be filed with the United States Securities and Exchange Commission (the &#8220;Commission&#8221;).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In connection with this opinion, we have examined the Registration Statement, the Company&#8217;s Articles and Memorandum of Association, as amended to date, and the originals, or copies certified to our satisfaction, of such records, documents, certificates, memoranda and other instruments as in our judgment are necessary or appropriate to enable us to render the opinions expressed below (collectively, the &#8220;Documents&#8221;).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following opinion is given only as to matters of British Virgin Islands law, and we express no opinion with respect to any matters governed by or construed in accordance with the laws of any jurisdiction other than the British Virgin Islands. We have assumed that there is nothing under any law (other than the laws of the British Virgin Islands) that would affect or vary the following opinion. We offer no opinion in relation to any representation or warranty given by any party to the Documents save as specifically hereinafter set forth. This opinion is strictly limited to the matters stated in it, does not apply by implication to other matters, and only relates to (1) those circumstances or facts specifically stated herein and (2) the laws of the British Virgin Islands, as they respectively exist at the date hereof.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In giving this opinion we have assumed, without independent verification:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the genuineness of all signatures and seals, the authenticity of all documents submitted to us as originals, the conformity of all copy documents or the forms of documents provided to us to their originals or, as the case may be, to the final form of the originals and that any markings showing revisions or amendments to documents are correct and complete;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;that the copies produced to us of minutes of meetings and/or of resolutions are true copies and correctly record the proceedings of such meetings and/or the subject matter which they propose to record and that all factual statements therein contained are true and correct and that any meetings referred to in such copies were duly convened and held and that all resolutions set out in such copy minutes or resolutions were duly passed and are in full force and effect and that all factual statements made in such resolutions, the Director&#8217;s Certificate and any other certificates and documents on which we have relied are true and correct (and continue to be true and correct);</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<hr style="COLOR: black" align="left" noshade size="1" width="100%">
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Disclosure Required by Internal Revenue Service Circular 230: This communication is not a tax opinion. To the extent it contains tax advice, it is not intended or written by the practitioner to be used, and it cannot be used by the taxpayer, for the purpose of avoiding tax penalties that may be imposed on the taxpayer by the Internal Revenue Service.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;that the statutory registers of directors and officers, members, mortgages and charges and the minute book of the Company are true, complete, accurate and up to date;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the accuracy of all representations, warranties and covenants as to factual matters made by the parties to the Documents; and</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;that there is no contractual or other prohibition (other than as may arise by virtue of the laws of the British Virgin Islands) binding on the Company or on any other party prohibiting it from entering into and performing its obligations.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Based upon the foregoing and in reliance thereon, it is our opinion that the common shares of the Company will, upon the receipt of full payment, issuance and delivery in accordance with the terms of the offering described in the Registration Statement and registration in the register of members (shareholders) of the Company, be fully and validly authorized, legally issued, fully paid and non-assessable.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The foregoing opinion is subject to the following reservations and qualifications:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the event that the Documents are executed in or brought within the jurisdiction of the British Virgin Islands (e.g., for the purposes of enforcement or obtaining payment), stamp duty may be payable.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;We neither express nor imply any opinion as to any representation or warranty given by the Company in the Documents as to its capability (financial or otherwise) to undertake the obligations assumed by it under the Documents.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To maintain the Company in good standing under the laws of the British Virgin Islands annual fees must be paid and annual returns made. The annual fees are payable by the Company and will not affect the non-assessable nature of the common shares.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We hereby consent to the use of this opinion as an exhibit to the Registration Statement and to the use of our name under the caption &#8220;Legal Matters&#8221; in the Prospectus constituting a part thereof. In giving such consent, we do not thereby admit that we come within the category of persons whose consent is required under section 7 of the U.S. Securities Act of 1933, as amended, or the Rules and Regulations of the Commission thereunder.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="50%">

<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Sincerely,</font></font></div>

<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></div>

<div align="justify">

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Kaufman &amp; Canoles, P.C.</font></font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Kaufman &amp; Canoles, P.C.</font></font></div>
</div>
</td>
</tr></table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>v244049_ex23-1.htm
<TEXT>
<html>
<head>
    <title>Unassociated Document</title>
    <!--Licensed to: Vintage Filings-->
    <!--Document Created using EDGARizerAgent 5.3.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><IMG SRC="logo2.jpg"></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To the Members of the Audit Committee</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dehaier Medical Systems Limited and Affiliate</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We consent to the incorporation by reference in the Registration Statement (Form S-8) of Dehaier Medical Systems Limited and Affiliate of our report dated March 7, 2011 with respect to the consolidated financial statements of Dehaier Medical Systems Limited and Affiliate included in the Annual Report (Form 10-K) for the years ended December 31, 2010 and 2009, and to the reference to our firm under the heading &#8220;Experts&#8221;.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">/s/ Friedman LLP</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">New York, New York</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">December 27, 2011</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`)D%D
M;V)E`&3``````0,`%00#!@H-```%1P``%]@``!RP```@^__;`(0``0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@("`@("
M`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"`@(!`@(#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\(`$0@`1P$1`P$1
M``(1`0,1`?_$`,4``0`#`0$!`0$````````````&!P@%!`D#`@$!````````
M`````````````!```@,!``(`!`<!````````!08#!`<"``$0@!8(0%!@$1(3
M-Q<1``$$`0,#`@4"`08/``````,!`@0%!A$2$P`A!Q05,4$B(Q80)$)183(S
M=C=`4&!Q4C0EE;75MM87AY<2`0```````````````````(`3`0$!``("`0(&
M`P````````$1`"$Q$$%1@&$@0%!@\'&!H<'_V@`,`P$``A$#$0```?OX````
M`````````````#-YS"[BC"7G8(*1,X!M\Q&76>\H4M8T:9T-%F*SL%B'O,_E
MXG[%3%LG;(F5Z2LJ8W8?N#X6GU),[%=&B22E6EF$"*0+1(H?J3,QP?:4RV:/
M,X%VF(#]3OE$FJS;A\Z3097AUSVE9&UR4`H\X9W#TG(*F+V+A*:*_)X<L]Q[
M2J#3A6)-3/9WR7G\'N*N+<*&+_,LEED:+`*L-H'3!\^CV'8.<6$54=T[!9Y#
M"KS0A51'R:FP``````````4V3LC!VR0$8(X2,]YPS]28D-.B=L[(````````
M`````````````````````````````````````````````````````/_:``@!
M`0`!!0+\DSYVLMT2P]$GH\QGJ*N`RI[,.8VTV7(-*T!CLJ"1H#H55L]]R?<#
M^VO:L5S#N.2.:/-=:N:"Z:*W6$Y=SQNX>DUKU_I.U36G2[GF>^=,Q_T.\B=7
MMWO+SVRTFW16ZPG+N>-W#TG7-BZ$:_H[7;2UI[=HDL?+8WVG$$>AS,DHA^PU
M)>H-9-*3?[/N`\:7$^K!#K=K>?CHY(YH_@&27[0:F9.0EP6MR.\6+]9YZJ[2
M3]_PWW<.^(\AVN*Q_P`6JK&N1VM.H4RNE4W$RJ9)G2_34]1<W+N79<F9>Z^D
MF0(EHVO2CI<9CA4C7#C>Q-X01BO>S8#`.Z/>.F64&+9'1R[EV7)F7NOI/TL(
M==&9F<S,@NGN"+:O,_\`Z9`6-_Y/]P?,O>8?2NR>/8I<8/#4NUY\'"%Z;`%^
M"0E1)?-E)J^GL.H1TW-_3H7M8=$.-OXLY>T-'3VI</"YX=4.#;5>RH3>T^HK
M5Z#XI+%'/1+2EQ,9GA2XX?\`7\@"ZZ$)CZQ8=.!:KU<`&]+XZYFA<<:4L[F#
M'4=,C3:;4EQ,9D4I<"W+2\C"Z19<DT,\AI4+4;L(]1"A5(-EVF+X@[GIYFS_
M`.AM<\/9]TS`K^9Z$R4*=.J.I_`$Q,%@Z*#S\`17HG[IVCK1`$O53,K?*V-4
MP"NQM@Q?N&&<F#SXC9M5F^\1M,8^8DU7]8_RQX,%.S91W9J8E&8SAXU^$K9X
MCT[,`016M]I:IV&K+@"F.]T:?5VVL+M\<05>>%CVL`.P`8"'7JQ5/5SE[TI+
M'->[3J$:9-263-_A<`1U*P^C3F_7G__:``@!`@`!!0+Y.__:``@!`P`!!0+Y
M.__:``@!`@(&/P(=_P#_V@`(`0,"!C\"'?\`_]H`"`$!`08_`O\`$F=&L8T.
M`S$_(>68>%X7DV&@8Z2.T4Z4X[E09R-*JOTT8FG1CXK`BKXYJUE0SY?.Y]^5
MW`7/"4&&QAO$PE)4G8K#V1=XI!D<(#'(QQ>KG([-RM@4=9-M)6U6[W"A`>=1
M!1ZM1\@VS8-O\3U1/GU;1LKI@XWF..6(8=[0B,I/3!LJZ)=4TI&O(4HV2J^<
MC%W*OW@DT[=4^$MC1E@V.'W61EEKR^K9)K;:IKQ`9]7#P/'/<KM4W:HG?^7*
M<GA`!)ET-)/LX\>5R>G,6*%Q&,-Q.83C54[Z*B]?E=5#KY-J0F+A!%L726U_
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M9-R=.;6BN+NZN*FJ]T5-X`4TL]6T"F<UC1&.U7O1O619C7Q(L^93,KG!B3%*
MV,7UEO7US^10.:7Z!S%<FB_%/TE9.@J;V*'838Q*C]W[R^#7VYJJ3,;9\_IF
MV^@'/96>CW.,B1E.UZ[F]6:>-*[&8F-4UE(J'YCF'NLR+D,^$0@+%N+TU,6"
M^765TH7$Z<26P)B:H)K^-Z]0\!\C55/7WES7SK'%K[')4HN.Y.RJ5'VL`42R
M:VSJKBNB%&9P5=(&X>]>1-K>1LRLBQK'(;:VJ<;Q:JEG6,"TR"\F#B0XY#)I
ML"`2DDE[M^R!_=/CU1Y-Z=T*3.C/%:5[V/&^NNH!RU]U7JPOWD;$LXI6,W:.
M<Q$=\^C>/;BK9'QXP<?@U^3"5^@,HR*/-EU51:;WH(8[@=;(9&<Q-W,-$5%1
MRN8EW!C1I9_?,9J^&5R\7#=Y!75$@GVG,?R"#,<YGRW(FNJ=NH+@5DK(<AO;
M$5+B^,P2#!+N[@["%:)THR.!6UL4(G%E3"_9C!;N=JNUKGV2UWBVZ02&,[%J
MZ3DM98R!L:YXX<'*;%Y:UTXNB-1QX``[E[N:G?HV94HSM8.!:%+7607Q)]=:
M5+9`YU/:Q5^Y&F0IL9PR)\%TW-56JURXKDTP(8\J_P`?JK>0"-O].$T^$&20
M8>5SR<3'$[:JJZ=3;^GBP)ED.PH*^*"S=(;!5]U?UM.KY#HG[A&";.W?3JO;
MX+\.O]4\._[QS7_E?6*175-9<9[EEC7X["K8<Z1$QT=T:&:9:6)YTF.2R'CU
M3&AF,JM`221$8S:BOW-=E&85N#9)BT'A?D(L.9?UE]30B'$.191!7$JRB7D>
M`)ZO(S6&]437LFJM843VD$5C2#(Q4<QXWHCF/:Y.SFN:O;]?-5'2W-?28S&\
MO^1)GHRI(*_,L@;:Q2_C]X^,:*>OQ58@&#*HG\I'G5VCFLV]!6OK$QR=C[_Q
MV^Q%PQ`+BEM5L;&-3H`+6"]"%!_M7L:UCP;?I8Y'#9A>`,I+[)H]G:!R_+J?
M&JZ-<V)<3Q.9&DQXDBOD28C6P[O)G1!*52,1HQ%3N[1JX_D!,2SG#J7/ZQF!
MWKLOI8E-6R<GA.DV6%2P&B3K%TVUEC65`1KU9M8YFFO?3$5?]*&\8Y<$*KV0
MI1Y#C97C9_I/8+ZE3^3KR*Y[D8BXI:LU<NB;R@48V_YWD<B)_.O2!&3TDKUO
MC@3"D!S>FD?EN,M:1\9SQ<O"3NK%<W7335.HQ)?E:BE1!R`DDQ1^,PQGR8["
MM<:.R3^7F6.XPT5N_:[;KKHO7A2KL8XY=?92?)D"=$,FHI,.9X]LX\F.5.VH
MS!(K5_F7J]P1DA4\A8MD`_#>,\I00I5C+N7AC8%>16-Y4`/\6FBF-4G]/T15
M7K(,8K^\*@\5^.*H#U8P;S)$F9(-\DK1HC/42R[BD7YD>J]5<=F)YGEE1XQJ
M"S9`L0K&V/#FV6Q$%`]T%+FP8CA5N*N(\#FN<]"S5^&WK/\`&S8]DV*U>8%7
MR)C5?E=4.JFNLGI$K\W8)[+">*6V1/6/+8QCD5B/*JM^:Y-CUY#'/J;?P;3P
MIL4GP>(N;9%]0WI]89`7Z/$1NCQ$:CVJCD1>O)_B;,)99V48?6X[-I;HR=\O
MP0N74D6HO5<NA%LJYZ)#L-R+]]J.Y"J]SNI]K*0KH]?$/+*P#.205H!N)PQA
M:MYI)E3:-GQ>]43Y]`R/)AQVX[+L_=;.@KRR2T^(W*\#X63SE(_;:C9+%OG&
MX@P84KCL4`-XY<]R6-0YXULZMTFL(5$8[]U&5\(RZ.<U&NW-<G?X=8$V`/A&
M"G6)*%L43AVL29*C7*$&J-<TONPC*[7OKUA^/SA/+=Y0>Z90;(XB\"4]6Z?:
MR2&(]KHH6Q%0:JW57.(UNG?JKC,Q/,LLJ/&-06=)%B%8VQX<VRR(@H'N@9<V
M#$<*MQ5Q2`<USGH6;\MO6?XV;'<FQ6KS$B^1,:K\KJAU4UUF](E?FXQ/983Q
MRVR)ZQY;&,<BL1Y55OS7SQBMZ%QJJYQ;QA&DH-6M,)R1\H+'EQGO85@YD*2-
MA@N5KD:1B+HOPZM/'V:$1^=8/EWCD<J8J.8F68R7.*$5)F<-I'EY&3F:"F[7
MDX)J*C]CGM&GA<\YFH"5ODJ#5%42JR-=GJZ4VCC[=@BS*J-(8-%75VCD3]//
MTN"S;5R_(WD`D-R,5K))PT-7$MI@'Z;31SVT<VCFZM5S7=>-_P"Q.-_\*B]6
M+(YDCG?D.#-#(<%)#0%=F^/H,SHZO$AT$_OLW-W?#5.O[WL?3_U8#_O/K"<-
MR3))M5FLR6:ZPVYHAEKK-;W%J]IK>P@?:L*X`%A3'\L62Y["!*J-U>U'MGWA
M;S%O*=)41IEI<0K&C=AV4/JX@RF..KE5$B=0RC@C-W+R1!J1&JC4W*C5J+ZN
M5ZU]W5P+>"I6<95AV404R,I!ZNV/X3)JFO9?URQ!6!+#\JS?(<U)R`:#T1<@
M(`CZ]FTA.8<;@[$717:_!.@^0**Y;23O2NJ<UA!C@D5^60(P46O;<,YP^DN*
M1'(L>:GWVAT$[<#Z.LGSH]H^UEY'`I*JL$X`F@H**I$8OM]>=KRE,*SLI1)9
MG*J-<]6Z-[:K,Q\DXU3(>>!/K+F*(9IE/;54X%A7V,1I%9]T)XZ(NCF*X;G-
MW)KU1SAV\S'LLQ@\B9CN4U(8[I%;*F1?2SQ.@SVRXTRIL1HB2(I-4(UJ)N^?
M46%Y'\A)E6,QI$.:?%ZG$H.,0+J7`D#DQ4R$_N5W*L:YAAH]8K%`)[T:KM=J
M)T;'B3GUS36-%8+*8!)+D]DO*^Z02"<4*?N%@<>NOT[M=%TT_3!LH=.?'?A,
MJ_DCAH!",L??J*12.8\RE8L;TR'Y$5&OW::=OCU6^3'3I0SP:X8#T0V-2LL;
M>&"S@5603?J^]85=7=20"5S7*Q'-5CF;5WW68+9;I&0T--2-JW"8SC;12+*4
MZ2(W,KSJ5++NW8FS;\5U[9'+L;IDHUM>W^:9-D%ALKHJ%FNYBD<AI)@UU;4U
M440D12\;&!5WTZZ)A.0AG+5W&$WA;*),;%;+=)J[&$6NOJ-S7F$T(;B(YJ*7
MZG#<-JHB]2<[]<]22,/@XE[;P)QL9"NK&X]=ZKEW.>1T_CV;$1-NNJZZ)#KI
M\V13V-9)<>LNH@6'/'%)XQV4$H'O%SPK`(V[F[V?=&-VJHU6NFUDQ'K%GQ31
M#\1'!,UAV*Q7@.-4(`X]=S'M5',>B*G=.G5EAE<)]4=KHTLL#'BUV12H.FU1
M^\-OSUT29+&FV0<%>)='N6.V,_C>-E0"0\]=">X5.(C$0M=5(UGI:IQD=^Z#
M7=Q`>K6O2,T;'\A&N,2UN_'>:&PIV13W6N1TLNBB9/C=E:O8K2V\:M/*K)=3
M:S==91`2D9)5C%>S5NO4K,,HR6;FF928'M([:5"BU%;4U*R/4NKJ&BA*0%>(
MY$8I7O(<Q%8GU]W[KIK[`MO9Y'DMSE-U9E%Z?U,^U,FP8(W/)]+$@0`!CC&C
MU:B#U3371,)R$,Y:NXPF]+91)C8K9;I-78PBU]]1N:\HFA#<1'-12_4X;AM5
M$7K+LO2<\S\K@8S!?`4",;"_&QV@VD9(0KE/ZM+/NBL;LV?%=>V-V1Y9JBYQ
MJSB2P6<07*^96@FQYYZ2<'F"R3#-+B#*-7;E`5FYG])Z.]FN?5B04N-9UEG6
M25@W-%<P7*^ONZ2P:USX%I!>Y5&1$7LJM<CFN<U5K+'S5,]I+S"E'IL)I:7*
MC0C->SB#D(YLF'7RVL?VDQX`R-<FYNU>FX90Q1U%*&JDU4,(&J_TXY0S-*=V
M]V^1)*8[BD>]RO*5RN<JJJKU6455YLDQJRG@1:VOC_\`CS%#<,.$%D>.-2F<
M0Q58)B)N>YSE^:JO1\/OLX-/N"V-?8IE:8]5Q2#=5WL.[A#]EBD%7N07HFBU
M5?J^+D7X=?WYR?\`YQA_6.QK;([)N78N4%C4YU51H-9:@NA`<"1,2`T1JY:^
MT&Y62X+FK'.)=J_PN1U#E_ETL_&Y@'Q;J'C^%UF,VMW#(B(2')NO=+;TL:4W
MZ3I'CBY1N<SLURIU%KX(!QH4&,"'$C"3:*/%C":&.`;?X1B$Q&I_,GZ^/K1D
M_+9=1FE]9`)86P<6@XS?TDK#,LRBED8[C\*=99#2`"M1&4"R^"6L?5)7(5^J
M><1KD%X3GO[UJ%(M1R@4&+4\@A8ZLIV#1\IA4"_>UZ<0V[4:[5R^*,,9D=M!
MA6F&6E]/LQK7#N[!:06+#A8Z&7Z!@(D51Y*0JN`)LM15[4Y-.9SKJGAY*8LZ
MG\KXSA$/*BPZLTZ147A,2F2UDA9#]HD65.W)#P-Z`:CR0T4K=_+KCF(?EV1"
MJVX7>VEC)"M.&VN9\"XQV%$/,GBIV>E1K+`KGI#9&W.VIV9N8[#ZUJW]I,M,
MWSS%K*SQ_P#%H-_9P<(L\O@1A`)?2:>@A6EU'Q]AY3P['H(4CTPQJK2!N;>Q
M?81XN#9K"6PBW4G%I]\7`S4E.>\;E!<7GV4"--QV/?GLX_&K)9X<"+R[W'(\
MMC9UMNR.E_G2UV,UWJZFNL9>,4B^WSX.-64Z*:O/:Y0E#.LX92[MT.2UK2@5
M&G%>P9TN_)-J+Q8KZW*04S;^CCR:NLL8E;.L,?FSZB]&X<SG!+$1SN`S0F5Q
MPE>X]-6V&6;:['X5E+CXH_$ZD=(:TEW(8-Y?W64SD?-`9*<J`B18QQAX"OEC
M,A8S6>`,GG7%A&G6V(DN9\>O;7"@'ER<<J+2?J(]?).P,]\A1$1I&Z"TV;7?
M5UY+_L!F7_3MCU>1JFQR[CQW&8\Z0W'W8C44]!:']VF!M<AN<GE<UFTT.*/2
M*"+)CQA#>^0,BG$C*"R24$<C/O'-8&@18PVP:WR5-DU,.I8-I=2$'=GR]KWB
M(]Z#CU+E3^-71JF58%-^&8_95>8$?'BB]]RK\FEXY7V6T48:PM8V&SYW`SC:
MH+:.[;MV?X*.7&Q6D')!+9.B%]"%ZUTIDKUR%JT>CFU6LW[KDC\37$^I45>K
M6?'KH8I=YP>\'8%C76:Q@>E"Z:FFV0]D7[>YR*JC1&KV1-(./+0UZ4U6;U-5
M!&'B'524]1MD5;QJPU:=C996M<%S'-&1S$^E53J'41::MCU==*%.@P!0P-BQ
MIP9ON0YHA(S:V8EBJR.7^L4ZJ]5W+KT.R6*!;`44T$4U1,]4.'(*`YXK#Z<C
M0&/&&YS==%<Q%^73JB735QJUTXUIZ18PVC':2)QK0UF#8C71[)UE)?(YV*TJ
M&>KT=N[]3,:Q0E;BXYHY("2$IV6;1LL>1+.4R*Z9#$>WD\SG^HDK(:IUWF&;
MZFNBXL6JB'H(4.!`B5IQ\P`1ZIH$K>+DW/8:`L8;@D1>09&->U4<B+T2)2UT
M:N`>0^9)2.S0DN81@Q$FS3NW'FS"""QKBE<\BM8U-=$3H-G;T5=/GA`R*DF1
M':XA88CNE!A2_@DZ""4]Q6!-R"81RN1$<JKU2Q&4-4*-CDMLZ@`&$$`J64Q7
MJA:Q@FL2%_6N30>UNU=--.W4NOGQ@S(,Z,>'-B21M-'E1)(G!D1CB>BL*$X7
MJUS5[*B]`M+6DKI\\`PA;(D1VO<0,4[Y40,IO]":&#+(XH&&1[0%<KV;7*J]
M5$!E-6-A8^<,JCB)"C^GIY,8)H\8]:'CV0BQX\DC&*/:K&O5$ZG2(D./&/:2
M6S;$P0L&2=+9%CPFR93VHBF,V)$&/<O?8Q$_R]__V@`(`0$#`3\A_1#X.+4N
MRMOD`.=:QE-R\0QCF/+^PE[8I%%.\C3\\Z"%#TJX8`(A>N'7#RO*D`)G^*;A
MBZ_=W29T:')8'VY<D_(]T=\>>B^7>:E\)3%:7AACO`/!;C3``@@:9'_A#""F
M(DXE7-`E\G"6K>-GK"'F8`4#6!30;WERXSWX=1$?6)C3F;RX4*=XOBP47$3:
M`'UM"_$@JHE=X-VIS@0NA=0[0GY'2;!9X*<MEXV>L).9&)R-(%-!K8S:2)7!
MY:LVL$6HYB.\L=(HC(B;$GK(M2A@[*S$T2OS=TMQ&<UR52(.H8N/;YY:8[D?
M/BO.<$.K]DJ=D$_(ST6Y(@/X.)"L;I-?/RO<8F;-<=CD6D0Q1PCY(1%Y1B?Y
M+$-<J!"JEK.P6*&X"*$7I?J2VE]/I)<O[^M,V3+OX@?>`(.3GC)TP(%5]:O8
M&^P<BM:'$[(E+I-(VI/$9O?($R^$\'M*@UI4SH:5BP!@3?8"9WF3?,/MA',N
M5S!E^E"):R,Z*<<2]/<%E%`V*J!>"20*5BJ)TI``$X6$$G=]I(6T98:1`WD:
MFVM*],^25^F0&UD+TCU%CJD3%DSLY0)K[U$RIO5WGB?TT05L5K$+01F0HUBK
MP<Q*44#:E6\?%VF#U$*0Z:+$H)&O3U(/NI&B#Q$QVJ.=<421+%V),'E\)EX<
MZ2<(@T1.Q<O>Q\<7]5=:>>!(Z'9#E*V';<%#V$>BO4A$*`#HGYNZ*^?FW3/6
MO<>Q&@O+NT]Z68Y[+XYZ9_ADJ1-&D<K_`$1@H3T%;K9]%XMS;*?,IP9`'K1/
MS_<IX+1[2`9UU_>F]VEN^%!@`J5(5.`39@XUGJ#A!Z#W0,,#(WT<>L$KOZ/^
M$"2P;(),@^JWPUR/7>?_`&1G0K.X`F.%N#23;&47VK)2R^'KF,!R#BE\WH!*
MH3:"480U.;9JXULX;J[RX)J&34/Y@,4:,]I&C)2G\_J,E3.W"R`W`<[]<-<C
MVUQ5W^"E0Q*!F^,++1&.`WH`'&0(*<!S*`N#JM1XK*GG:X4Z]AL3*/Q/8TN&
M(9-L(AE07`D/:2)E>@'N%_`/^9\;3]JGQQV0F)#&/M'B$6URJ/B$*+"R-?7D
M%731.$J76JS"<+AU\)(S/">1]/VSD%S]86)U4>G#T&%*YC#M(2KH8&)ZAQ&6
M#CS($2LZ:I`)L+P=DC3TQJD!#0`)V<V/1^OD3C8L%(P7A'9X>93+W:.`1%_*
M-KKL/GZ7"%9RH3I#9UIHE';3P5=)J+I&Q(F7]OB(8[^5EE@TO)=I?LD;IXNL
M'[@:PF)\Y6&Z`HH.]0CJOH8*JTM(J*R>O]0E4DE:V*,9D.LO*+:S@6<+YTH9
MM?P,MR(Q.<\?`34%%E)$^3ZBI4,L0[#6CJ9&)T7@C3K]$JV)L.\A3>5M=TGJ
ML/#E8BFT'<<\SZWH5UY7V6.@B*8]$2L'&SZCIC]^_P#_V@`(`0(#`3\A^CO_
MV@`(`0,#`3\A^CO_V@`,`P$``A$#$0``$``````````````````)()(!!(`(
M))`)```(`(``!``!!)`!(!````))!`()))!!```)!((`((!)))(`````````
M``)!`!(!(```````````````````````````````````````````````````
M``````````!__]H`"`$!`P$_$/T2>"_KQMCD1%@%)W>XJQ`U5E))>X.6'(>[
M2(*=M;]TJ#;"TCA85`^R-GI&B)$*6P&!9H5R'XWU85PW1*>7/+UT9=NW/#PK
M.L5UA1\<'E;0BPQ]7I/_`*S%(B.(LH"2(82S7._/0B(QJ[*L@Q/1E)-GC4XY
M#-NR_1-1(BE0U[.V8)A#*JOP5O\`$V^A3J?5RF,Y&$Z/U828@O@^219M*Q@Q
MR/I0J#7'S.@PW1PVH.#TPI`P\B"M_ASI;U5[CZ-.!RPLH$\";$)DH!7T(\I'
M"MJR0$9*;+L6;<W?84W]Z-&+$)`/D@YQ#N_NP1#B0)$<OHEZH_ZN>*T5X\R+
MH'GH$\1`C0/!&H^R/3GN1Y&I&1C^#OX1(@$JKDZ0$+'`<^.\&A$8'\58L+&,
M*:)@$90`Z*0&E`I3@F9:<>5`S:J&+.`/<T0Y3`B(60<<N9&U@(7P%Q#">@T@
MH!]P!+F[Y!A.\)-]D<&%"%!1#"&PGESEVOE38^!/+NSX,"O!LV)"F`<PX^F/
M&;%$C#X8SZ9JD"=#!BVWNIF6NWP6$7R>'`H4Z+@T)#A@0=*^@C4**J<Z+*9[
M&\T*E;R8<<3@^EV:&6@`:FU/-1065/#D;)8M'\TP_F,0]B_4D&*6'.%);NR8
MQZI&.E;W=<S^T\)GLK"K,%ZPL4<2:;@PX)N^(HH\0Y"7<[.W^%OWNE[0;,?I
MR_=KD%"=0Z$]JBL1KFIDQ`/@+/`KX%(/XY)025OL`9`(]6"'+$]53,9-KDXV
MGCYBL;EN3_H"07@H9!]?[!ZP%M\'KZI^4V[(T`)YN>HVC!YSQ'6RO'`]9SEI
M1R!Y=G_UN6Q`S1&#\@"'QB3(8<VSJJ+&*'ASQ50Y)C`7EOC%[1AOC7#@=PEK
M93[Z*QWK4\V?>K1JY`PP"Z#R'P\AA2V*K(\X#RSPE.H!&:+P'!SM18#J(#=@
MU=>F9,:PWRY7ZB`@T.`XL,\/H5:?&(R38>IBD=0P)TE'9LLRYMB85GH8+5TM
MM<`B)(77'HV$5>`;Q2V2,_XAL/,R=I7TS<A'!9[(U_;-)(ZSF_'_`&.#[<M\
MII<0A&]F6>FY2_8F#,[`C&(;X<)*4(LAZ\HOM!5933&Y-5B+WPY"(.>'Y_C9
M>!WL8(3.XG`OM-2P3*#A)L]'(7V\G/O-.P"20<V_F17LAI3%2[)Q>6-CC_>8
M^UA*`A;<+H,?$Y_D[/+U-/'\1XNS\6$*4/"SX%`*O@Q-Q/R<1)XA/7%9Z,=3
MD'!Z63L942Z'Y5:HNW!/U0,E2H"K-NX,MR21*&=4!J>X3>LP'=**^WK4;"FR
M5J0]^`)\0A8;-4DJ8L3H9\6/[,;3IWXUQ6&:24_BL?#B`_D'Q]#C8TD;?G_2
M",$$[D`%<M1K\*:S'@\)S$FU`+]J&/.8IXW-@EZQ2@Y]H-DXGBSQ'W8B[%JJ
>1&)^_?_:``@!`@,!/Q#Z.__:``@!`P,!/Q#Z.__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>v244049_ex99-1.htm
<TEXT>
<html>
<head>
    <title>Unassociated Document</title>
    <!--Licensed to: Vintage Filings-->
    <!--Document Created using EDGARizerAgent 5.3.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 99.1</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">DEHAIER MEDICAL SYSTEMS LIMITED</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">2009 SHARE INCENTIVE PLAN</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Purpose and Effective Date</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) The purpose of the Dehaier Medical Systems Limited 2009 Share Incentive Plan (the &#8220;Plan&#8221;) is to further the long term stability and financial success of Dehaier Medical Systems Limited (the &#8220;Company&#8221;) by attracting and retaining personnel, including employees, non-employee directors, and consultants, through the use of stock incentives. It is believed that ownership of Company stock will stimulate the efforts of those employees upon whose judgment, interest and efforts the Company is and will be largely dependent for the successful conduct of its business.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) The Plan was adopted by the Board of Directors and the shareholders of the Company on November 20, 2009 (the &#8220;Effective Date&#8221;).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Definitions</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Act</font>. The Securities Exchange Act of 1934, as amended.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Affiliate</font>. The meaning assigned to the term &#8220;affiliate&#8221; under Rule 12b-2 of the Act.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Applicable Withholding Taxes</font>. The aggregate amount of federal, state and local income and payroll taxes that the Company is required to withhold (based on the minimum applicable statutory withholding rates) in connection with any exercise of an Option or the award, lapse of restrictions or payment with respect to Restricted Stock.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Award</font>. The award of an Option or Restricted Stock under the Plan.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Beneficiary</font>. The person or persons entitled to receive a benefit pursuant to an Award upon the death of a Participant.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Board</font>. The Board of Directors of the Company.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Cause</font>. Dishonesty, fraud, misconduct, gross incompetence, gross negligence, breach of a material fiduciary duty, material breach of an agreement with the Company, unauthorized use or disclosure of confidential information or trade secrets, or conviction or confession of a crime punishable by law (except minor violations), in each case as determined by the Committee, which determination shall be binding. Notwithstanding the foregoing, if &#8220;Cause&#8221; is defined in an employment agreement between a Participant and the Company, &#8220;Cause&#8221; shall have the meaning assigned to it in such agreement.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Change of Control</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 54pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i) The acquisition by any unrelated person of beneficial ownership (as that term is used for purposes of the Act) of 50% or more of the then outstanding common shares of the Company or the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors. The term &#8220;unrelated person&#8221; means any person other than (x)&#160;the Company and its subsidiaries, (y)&#160;an employee benefit plan or related trust sponsored by the Company or its subsidiaries, and (z)&#160;a person who acquires stock of the Company pursuant to an agreement with the Company that is approved by the Board in advance of the acquisition. For purposes of this subsection, a &#8220;person&#8221; means an individual, entity or group, as that term is used for purposes of the Act;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 54pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii) Any tender or exchange offer, merger or other business combination, sale of assets or any combination of the foregoing transactions, and the Company is not the surviving corporation; and</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div>&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 54pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii) A liquidation of the Company.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Code</font>. The Internal Revenue Code of 1986, as amended.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(j)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Committee</font>. The Compensation Committee of the Board.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(k)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Company</font>. Dehaier Medical Systems Limited.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(l)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Company Stock</font>. The common shares of the Company. In the event of a change in the capital structure of the Company (as provided in Section&#160;12 below), the shares resulting from such a change shall be deemed to be Company Stock within the meaning of the Plan.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(m)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Consultant</font>. A person rendering services to the Company who is not an &#8220;employee&#8221; for purposes of employment tax withholding under the Code.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(n)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Corporate Change</font>. A consolidation, merger, dissolution or liquidation of the Company, or a sale or distribution of assets or stock (other than in the ordinary course of business) of the Company; provided that, unless the Committee determines otherwise, a Corporate Change shall only be considered to have occurred with respect to Participants whose business unit is affected by the Corporate Change.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(o)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Date of Grant</font>. The date as of which an Award is made by the Committee.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(p)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Disability or Disabled</font>. As to an Incentive Stock Option, a Disability within the meaning of Code Section&#160;22(e)(3). As to all other Incentive Awards, the Committee shall determine whether a Disability exists and such determination shall be conclusive.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(q)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Fair Market Value</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 54pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i) If Company Stock is traded on a national securities exchange, the average of the highest and lowest registered sales prices of Company Stock on such exchange;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 54pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii) If Company Stock is traded in the over-the-counter market, the average between the closing bid and asked prices as reported by the NASDAQ Stock Market; or</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 54pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii) If shares of Company Stock are not publicly traded, the Fair Market Value shall be determined by the Committee using any reasonable method in good faith.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Fair Market Value shall be determined as of the applicable date specified in the Plan or, if there are no trades on such date, the value shall be determined as of the last preceding day on which Company Stock is traded.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(r)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Incentive Stock Option</font>. An Option intended to meet the requirements of, and qualify for favorable Federal income tax treatment under, Code Section&#160;422.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(s)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Nonstatutory Stock Option</font>. An Option that does not meet the requirements of Code Section&#160;422, or that is otherwise not intended to be an Incentive Stock Option and is so designated.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(t)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Option</font>. A right to purchase Company Stock granted under the Plan, at a price determined in accordance with the Plan.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(u)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Participant</font>. Any individual who receives an Award under the Plan.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(v)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Restricted Stock</font>. Company Stock awarded upon the terms and subject to the restrictions set forth in Section&#160;7 below.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt">2</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div>&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(w)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Rule 16b-3</font>. Rule 16b-3 of the Act, including any corresponding subsequent rule or any amendments to Rule 16b-3 enacted after the effective date of the Plan.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(x)&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">10% Shareholder</font>. A person who owns, directly or indirectly, stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or an Affiliate. Indirect ownership of stock shall be determined in accordance with Code Section&#160;424(d).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">General</font>. Awards of Options and Restricted Stock may be granted under the Plan. Options granted under the Plan may be Incentive Stock Options or Nonstatutory Stock Options.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Stock</font>. Subject to Section&#160;12 of the Plan, there shall be reserved for issuance under the Plan a total of 450,000 unissued shares of Company Stock. Shares allocable to Options granted under the Plan that expire or otherwise terminate unexercised and shares that are forfeited pursuant to restrictions on Restricted Stock awarded under the Plan may again be subjected to an Award under this Plan. For purposes of determining the number of shares that are available for Awards under the Plan, such number shall, if permissible under Rule 16b-3, include the number of shares surrendered by a Participant or retained by the Company (a)&#160;in connection with the exercise of an Option or (b)&#160;in payment of Applicable Withholding Taxes.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Eligibility</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) Any employee of, non-employee director of, or Consultant to the Company or its affiliates, who, in the judgment of the Committee, has contributed or can be expected to contribute to the profits or growth of the Company is eligible to become a Participant. The Committee shall have the power and complete discretion, as provided in Section&#160;14, to select eligible Participants and to determine for each Participant the terms, conditions and nature of the Award and the number of shares to be allocated as part of the Award; provided, however, that any award made to a member of the Committee must be approved by the Board. The Committee is expressly authorized to make an Award to a Participant conditioned on the surrender for cancellation of an existing Award.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) The grant of an Award shall not obligate the Company to pay an employee any particular amount of remuneration, to continue the employment of the employee after the grant or to make further grants to the employee at any time thereafter.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) Non-employee directors and Consultants shall not be eligible to receive the Award of an Incentive Stock Option.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Stock Options</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) Whenever the Committee deems it appropriate to grant Options, notice shall be given to the Participant stating the number of shares for which Options are granted, the Option price per share, whether the options are Incentive Stock Options or Nonstatutory Stock Options, and the conditions to which the grant and exercise of the Options are subject. This notice, when duly accepted in writing by the Participant, shall become a stock option agreement between the Company and the Participant.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) The Committee shall establish the exercise price of Options. The exercise price of an Incentive Stock Option shall be not less than 100% of the Fair Market Value of such shares on the Date of Grant, provided that if the Participant is a 10% Shareholder, the exercise price of an Incentive Stock Option shall be not less than 110% of the Fair Market Value of such shares on the Date of Grant. The exercise price of a Nonstatutory Stock Option Award shall not be less than 100% of the Fair Market Value of the shares of Company Stock covered by the Option on the Date of Grant.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) Options may be exercised in whole or in part at such times as may be specified by the Committee in the Participant&#8217;s stock option agreement. The Committee may impose such vesting conditions and other requirements as the Committee deems appropriate, and the Committee may include such provisions regarding a Change of Control or Corporate Change as the Committee deems appropriate.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt">3</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div>&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d) The Committee shall establish the term of each Option in the Participant&#8217;s stock option agreement. The term of an Incentive Stock Option shall not be longer than ten years from the Date of Grant, except that an Incentive Stock Option granted to a 10% Shareholder may not have a term in excess of five years. No option may be exercised after the expiration of its term or, except as set forth in the Participant&#8217;s stock option agreement, after the termination of the Participant&#8217;s employment. The Committee shall set forth in the Participant&#8217;s stock option agreement when, and under what circumstances, an Option may be exercised after termination of the Participant&#8217;s employment or period of service; provided that no Incentive Stock Option may be exercised after (i)&#160;three months from the Participant&#8217;s termination of employment with the Company for reasons other than Disability or death, or (ii)&#160;one year from the Participant&#8217;s termination of employment on account of Disability or death. The Committee may, in its sole discretion, amend a previously granted Incentive Stock Option to provide for more liberal exercise provisions, provided however that if the Incentive Stock Option as amended no longer meets the requirements of Code Section&#160;422, and, as a result the Option no longer qualifies for favorable federal income tax treatment under Code Section&#160;422, the amendment shall not become effective without the written consent of the Participant.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e) An Incentive Stock Option, by its terms, shall be exercisable in any calendar year only to the extent that the aggregate Fair Market Value (determined at the Date of Grant) of Company Stock with respect to which Incentive Stock Options are exercisable by the Participant for the first time during the calendar year does not exceed $100,000 (the &#8220;Limitation Amount&#8221;). Incentive Stock Options granted under the Plan and all other plans of the Company and any parent or Subsidiary of the Company shall be aggregated for purposes of determining whether the Limitation Amount has been exceeded. The Board may impose such conditions as it deems appropriate on an Incentive Stock option to ensure that the foregoing requirement is met. If Incentive Stock Options that first become exercisable in a calendar year exceed the Limitation Amount, the excess Options will be treated as Nonstatutory Stock Options to the extent permitted by law.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f) If a Participant dies and if the Participant&#8217;s stock option agreement provides that part or all of the Option may be exercised after the Participant&#8217;s death, then such portion may be exercised by the personal representative of the Participant&#8217;s estate during the time period specified in the stock option agreement.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g) If a Participant&#8217;s employment or services is terminated by the Company for Cause, the Participant&#8217;s Options shall terminate as of the date of the misconduct.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Restricted Stock Awards</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) Whenever the Committee deems it appropriate to grant a Restricted Stock Award, notice shall be given to the Participant stating the number of shares of Restricted Stock for which the Award is granted and the terms and conditions to which the Award is subject. This notice, when accepted in writing by the Participant, shall become an Award agreement between the Company and the Participant. Certificates representing the shares shall be issued in the name of the Participant, subject to the restrictions imposed by the Plan and the Committee. A Restricted Stock Award may be made by the Committee in its discretion without cash consideration.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) The Committee may place such restrictions on the transferability and vesting of Restricted Stock as the Committee deems appropriate, including restrictions relating to continued employment and financial performance goals. Without limiting the foregoing, the Committee may provide performance or Change of Control or Corporate Change acceleration parameters under which all, or a portion, of the Restricted Stock will vest on the Company&#8217;s achievement of established performance objectives. Restricted Stock may not be sold, assigned, transferred, disposed of, pledged, hypothecated or otherwise encumbered until the restrictions on such shares shall have lapsed or shall have been removed pursuant to subsection (c)&#160;below.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) The Committee may provide in a Restricted Stock Award, or subsequently, that the restrictions will lapse if a Change of Control or Corporate Change occurs. The Committee may at any time, in its sole discretion, accelerate the time at which any or all restrictions will lapse or may remove restrictions on Restricted Stock as it deems appropriate.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt">4</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div>&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d) A Participant shall hold shares of Restricted Stock subject to the restrictions set forth in the Award agreement and in the Plan. In other respects, the Participant shall have all the rights of a shareholder with respect to the shares of Restricted Stock, including, but not limited to, the right to vote such shares and the right to receive all cash dividends and other distributions paid thereon. Certificates representing Restricted Stock shall bear a legend referring to the restrictions set forth in the Plan and the Participant&#8217;s Award agreement. If stock dividends are declared on Restricted Stock, such stock dividends or other distributions shall be subject to the same restrictions as the underlying shares of Restricted Stock.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Method of Exercise of Options</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) Options may be exercised by giving written notice of the exercise to the Company, stating the number of shares the Participant has elected to purchase under the Option. Such notice shall be effective only if accompanied by the exercise price in full in cash; provided that, if the terms of an Option so permit, the Participant may (i)&#160;deliver Company Stock that the Participant has owned for at least six months (valued at Fair Market Value on the date of exercise), or (ii)&#160;exercise any applicable net exercise provision contained therein. Unless otherwise specifically provided in the Option, any payment of the exercise price paid by delivery of Company Stock acquired directly or indirectly from the Company shall be paid only with shares of Company Stock that have been held by the Participant for more than six months (or such longer or shorter period of time required to avoid a charge to earnings for financial accounting purposes).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) Notwithstanding anything herein to the contrary, Awards shall always be granted and exercised in such a manner as to conform to the provisions of Rule 16b-3.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9.&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Applicable Withholding Taxes</font>. Each Participant shall agree, as a condition of receiving an Award, to pay to the Company, or make arrangements satisfactory to the Company regarding the payment of, all Applicable Withholding Taxes with respect to the Award. Until the Applicable Withholding Taxes have been paid or arrangements satisfactory to the Company have been made, no stock certificates (or, in the case of Restricted Stock, no stock certificates free of a restrictive legend) shall be issued to the Participant. As an alternative to making a cash payment to the Company to satisfy Applicable Withholding Tax obligations, the Committee may establish procedures permitting the Participant to elect to (a)&#160;deliver shares of already owned Company Stock (subject to such restrictions as the Committee may establish, including a requirement that any shares of Company Stock so delivered shall have been held by the Participant for not less than six months) or (b)&#160;have the Company retain that number of shares of Company Stock that would satisfy all or a specified portion of the Applicable Withholding Taxes. Any such election shall be made only in accordance with procedures established by the Committee and in accordance with Rule 16b-3.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10.&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Nontransferability of Awards</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) In general, Awards, by their terms, shall not be transferable by the Participant except by will or by the laws of descent and distribution or except as described below. Options shall be exercisable, during the Participant&#8217;s lifetime, only by the Participant or by his guardian or legal representative.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) Notwithstanding the provisions of (a)&#160;and subject to federal and state securities laws, the Committee may grant Nonstatutory Stock Options that permit a Participant to transfer the Options to one or more immediate family members, to a trust for the benefit of immediate family members, or to a partnership, limited liability company, or other entity the only partners, members, or interest-holders of which are among the Participant&#8217;s immediate family members. Consideration may not be paid for the transfer of Options. The transferee of an Option shall be subject to all conditions applicable to the Option prior to its transfer. The agreement granting the Option shall set forth the transfer conditions and restrictions. The Committee may impose on any transferable Option and on stock issued upon the exercise of an Option such limitations and conditions as the Committee deems appropriate.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">11.&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Termination, Modification, Change</font>. If not sooner terminated by the Board, this Plan shall terminate at the close of business on the tenth anniversary of the Effective Date. No Awards shall be made under the Plan after its termination. The Board may terminate the Plan or may amend the Plan in such respects as it shall deem advisable; provided that, if and to the extent required by Rule 16b-3, no change shall be made that increases the total number of shares of Company Stock reserved for issuance pursuant to Awards granted under the Plan (except pursuant to Section&#160;12), expands the class of persons eligible to receive Awards, or materially increases the benefits accruing to Participants under the Plan, unless such change is authorized by the shareholders of the Company. Notwithstanding the foregoing, the Board may unilaterally amend the Plan and Awards as it deems appropriate to ensure compliance with Rule 16b-3 and to cause Incentive Stock Options to meet the requirements of the Code and regulations thereunder. Except as provided in the preceding sentence, a termination or amendment of the Plan shall not, without the consent of the Participant, adversely affect a Participant&#8217;s rights under an Award previously granted to him.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt">5</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div>&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">12.&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Change in Capital Structure</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) In the event of a stock dividend, stock split or combination of shares, spin-off, reclassification, recapitalization, merger or other change in the Company&#8217;s capital stock (including, but not limited to, the creation or issuance to shareholders generally of rights, options or warrants for the purchase of common shares or preferred stock of the Company), the number and kind of shares of stock or securities of the Company to be issued under the Plan (under outstanding Awards and Awards to be granted in the future), the exercise price of options, and other relevant provisions shall be appropriately adjusted by the Committee, whose determination shall be binding on all persons. If the adjustment would produce fractional shares with respect to any Award, the Committee may adjust appropriately the number of shares covered by the Award so as to eliminate the fractional shares.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) In the event the Company distributes to its shareholders a dividend<font style="DISPLAY: inline; FONT-WEIGHT: bold">,</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>or sells or causes to be sold to a person other than the Company or a Subsidiary shares of stock in any corporation (a &#8220;Spinoff Company&#8221;) which, immediately before the distribution or sale, was a majority owned Subsidiary of the Company, the Committee shall have the power, in its sole discretion, to make such adjustments as the Committee deems appropriate. The Committee may make adjustments in the number and kind of shares or other securities to be issued under the Plan (under outstanding Awards and Awards to be granted in the future), the exercise price of Options, and other relevant provisions, and, without limiting the foregoing, may substitute securities of a Spinoff Company for securities of the Company. The Committee shall make such adjustments as it determines to be appropriate, considering the economic effect of the distribution or sale on the interests of the Company&#8217;s shareholders and the Participants in the businesses operated by the Spinoff Company, and subject to the proviso that any such adjustments or new options shall not be made or granted, respectively, that would result in subjecting the Plan to variable plan accounting treatment. The Committee&#8217;s determination shall be binding on all persons. If the adjustment would produce fractional shares with respect to any Award, the Committee may adjust appropriately the number of shares covered by the Award so as to eliminate the fractional shares.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) To the extent required to avoid a charge to earnings for financial accounting purposes, adjustments made by the Committee pursuant to this Section&#160;12 to outstanding Awards shall be made so that both (i)&#160;the aggregate intrinsic value of an Award immediately after the adjustment is not greater than or less than the Award&#8217;s aggregate intrinsic value before the adjustment and (ii)&#160;the ratio of the exercise price per share to the market value per share is not reduced.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d) Notwithstanding anything in the Plan to the contrary, the Committee may take the foregoing actions without the consent of any Participant, and the Committee&#8217;s determination shall be conclusive and binding on all persons for all purposes. The Committee shall make its determinations consistent with Rule 16b-3 and the applicable provisions of the Code.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">13.&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Change of Control</font>. In the event of a Change of Control or Corporate Change, the Committee may take such actions with respect to Awards as the Committee deems appropriate. These actions may include, but shall not be limited to, the following:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) At the time the Award is made, provide for the acceleration of the vesting schedule relating to the exercise or realization of the Award so that the Award may be exercised or realized in full on or before a date initially fixed by the Committee;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt">6</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div>&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) Provide for the purchase or settlement of any such Award by the Company for any amount of cash equal to the amount which could have been obtained upon the exercise of such Award or realization of a Participant&#8217;s rights had such Award been currently exercisable or payable;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) Make adjustments to Awards then outstanding as the Committee deems appropriate to reflect such Change of Control or Corporate Change; provided, however, that to the extent required to avoid a charge to earnings for financial accounting purposes, such adjustments shall be made so that both (i)&#160;the aggregate intrinsic value of an Award immediately after the adjustment is not greater than or less than the Award&#8217;s aggregate intrinsic value before the Award and (ii)&#160;the ratio of the exercise price per share to the market value per share is not reduced; or</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d) Cause any such Award then outstanding to be assumed, or new rights substituted therefore, by the acquiring or surviving legal entity in such Change of Control or Corporate Change.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">14.&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Administration of the Plan</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) The Plan shall be administered by the Committee, who shall be appointed by the Board. The Board may designate the Compensation Committee of the Board, or a subcommittee of the Compensation Committee, to be the Committee for purposes of the Plan. If and to the extent required by Rule 16b-3, all members of the Committee shall be &#8220;Non-Employee Directors&#8221; as that term is defined in Rule 16b-3, and the Committee shall be comprised solely of two or more &#8220;outside directors&#8221; as that term is defined for purposes of Code section 162(m). If any member of the Committee fails to qualify as an &#8220;outside director&#8221; or (to the extent required by Rule 16b-3) a &#8220;Non-Employee Director,&#8221; such person shall immediately cease to be a member of the Committee and shall not take part in future Committee deliberations. The Board of Directors may from time to time may appoint members of the Committee and fill vacancies, however caused, in the Committee.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) The Committee shall have the authority to impose such limitations or conditions upon an Award as the Committee deems appropriate to achieve the objectives of the Award and the Plan. Without limiting the foregoing and in addition to the powers set forth elsewhere in the Plan, the Committee shall have the power and complete discretion to determine (i)&#160;which eligible persons shall receive an Award and the nature of the Award, (ii)&#160;the number of shares of Company Stock to be covered by each Award, (iii)&#160;whether Options shall be Incentive Stock options or Nonstatutory Stock Options, (iv)&#160;the Fair Market Value of Company Stock, (v)&#160;the time or times when an Award shall be granted, (vi)&#160;whether an Award shall become vested over a period of time, according to a performance-based vesting schedule or otherwise, and when it shall be fully vested, (vii)&#160;the terms and conditions under which restrictions imposed upon an Award shall lapse, (viii)&#160;whether a Change of Control or Corporate Change exists, (ix)&#160;the terms of incentive programs, performance criteria and other factors relevant to the issuance of Incentive Stock or the lapse of restrictions on Restricted Stock or Options, (x)&#160;when Options may be exercised, (xi)&#160;whether to approve a Participant&#8217;s election with respect to Applicable Withholding Taxes, (xii)&#160;conditions relating to the length of time before disposition of Company Stock received in connection with an Award is permitted, (xiii)&#160;notice provisions relating to the sale of Company Stock acquired under the Plan, and (xiv)&#160;any additional requirements relating to Awards that the Committee deems appropriate. Notwithstanding the foregoing, no &#8220;tandem stock options&#8221; (where two stock options are issued together and the exercise of one option affects the right to exercise the other option) may be issued in connection with Incentive Stock Options.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) The Committee shall have the power to amend the terms of previously granted Awards so long as the terms as amended are consistent with the terms of the Plan and, where applicable, consistent with the qualification of an option as an Incentive Stock Option. The consent of the Participant must be obtained with respect to any amendment that would adversely affect the Participant&#8217;s rights under the Award, except that such consent shall not be required if such amendment is for the purpose of complying with Rule 16b-3 or any requirement of the Code applicable to the Award.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d) The Committee may adopt rules and regulations for carrying out the Plan. The Committee shall have the express discretionary authority to construe and interpret the Plan and the Award agreements, to resolve any ambiguities, to define any terms, and to make any other determinations required by the Plan or an Award agreement. The interpretation and construction of any provisions of the Plan or an Award agreement by the Committee shall be final and conclusive. The Committee may consult with counsel, who may be counsel to the Company, and shall not incur any liability for any action taken in good faith in reliance upon the advice of counsel.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt">7</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div>&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e) A majority of the members of the Committee shall constitute a quorum, and all actions of the Committee shall be taken by a majority of the members present. Any action may be taken by a written instrument signed by all of the members, and any action so taken shall be fully effective as if it had been taken at a meeting.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">15.&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Issuance of Company Stock</font>. The Company shall not be required to issue or deliver any certificate for shares of Company Stock before (i)&#160;the admission of such shares to listing on any stock exchange on which Company Stock may then be listed, (ii)&#160;receipt of any required registration or other qualification of such shares under any state or federal securities law or regulation that the Company&#8217;s counsel shall determine is necessary or advisable, and (iii)&#160;the Company shall have been advised by counsel that all applicable legal requirements have been complied with. The Company may place on a certificate representing Company Stock any legend required to reflect restrictions pursuant to the Plan, and any legend deemed necessary by the Company&#8217;s counsel to comply with federal or state securities laws. The Company may require a customary written indication of a Participant&#8217;s investment intent. Until a Participant has been issued a certificate for the shares of Company Stock acquired, the Participant shall possess no shareholder rights with respect to the shares.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">16.&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Rights Under the Plan</font>. Title to and beneficial ownership of all benefits described in the Plan shall at all times remain with the Company. Participation in the Plan and the right to receive payments under the Plan shall not give a Participant any proprietary interest in the Company or any Affiliate or any of their assets. No trust fund shall be created in connection with the Plan, and there shall be no required funding of amounts that may become payable under the Plan. A Participant shall, for all purposes, be a general creditor of the Company. The interest of a Participant in the Plan cannot be assigned, anticipated, sold, encumbered or pledged and shall not be subject to the claims of his creditors.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">17.&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Beneficiary</font>. A Participant may designate, on a form provided by the Committee, one or more beneficiaries to receive any payments under Awards of Restricted Stock or Incentive Stock after the Participant&#8217;s death. If a Participant makes no valid designation, or if the designated beneficiary fails to survive the Participant or otherwise fails to receive the benefits, the Participant&#8217;s beneficiary shall be the first of the following persons who survives the Participant: (a)&#160;the Participant&#8217;s surviving spouse, (b)&#160;the Participant&#8217;s surviving descendants,&#160;<font style="DISPLAY: inline; FONT-STYLE: italic">per stirpes</font>, or (c)&#160;the personal representative of the Participant&#8217;s estate.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">18.&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Notice</font>. All notices and other communications required or permitted to be given under this Plan shall be in writing and shall be deemed to have been duly given if delivered personally or mailed first class, postage prepaid, as follows: (a)&#160;if to the Company&#8212;at its principal business address to the attention of the Secretary; (b)&#160;if to any Participant&#8212;at the last address of the Participant known to the sender at the time the notice or other communication is sent.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">19.&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Interpretation</font>. The terms of this Plan and Awards granted pursuant to the Plan are subject to all present and future regulations and rulings of the Secretary of the Treasury relating to the qualification of Incentive Stock Options under the Code or compliance with Code section 162(m), to the extent applicable, and they are subject to all present and future rulings of the Securities and Exchange Commission with respect to Rule 16b-3. If any provision of the Plan or an Award conflicts with any such regulation or ruling, to the extent applicable, the Committee shall cause the Plan to be amended, and shall modify the Award, so as to comply, or if for any reason amendments cannot be made, that provision of the Plan and/or the Award shall be void and of no effect.</font></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>logo2.jpg
<TEXT>
begin 644 logo2.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`)D%D
M;V)E`&3``````0,`%00#!@H-```31```.ED``$ZC``!G=O_;`(0``0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@("`@("
M`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"`@(!`@(#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\(`$0@`B0'T`P$1
M``(1`0,1`?_$`3(``0`#`0`"`P$````````````'"`D&`P4!`@0*`0$``@,!
M`0$``````````````08$!0<#`@@0``$#`P$#"@0%!`,```````0#!08``@<!
M$#0((%`1$Q05-18V-S`2,QA`(3$R%W"`(B9@04,1``$$``4"`0,."`@+"0``
M``,!`@0%`!$2$P8A%#%!(A40(%%A<3(CLW34=;46!U"!0G.TE39V8C,D-)0U
MU2:1H5)RDD-3TZ66%V!PT:+2)>6FMA(``0,!`@<,!@<&!@,``````0`"`Q$2
M!"$Q47&Q,A,006&!D:'!T>$B<C,@0K)SLQ0P4%)BHB-#\))3@R0%<(#QXO(T
M8T05$P$!``(!`@4$`@(#`0$````!$0`A,4%1$/!A<8$@D:&QP=$P4'#A\6"`
M_]H`#`,!``(1`Q$```'?P````````````````````````````````````'((
MZ](``````````````````````````````C:8DF)`````````````````````
M`````````$;3$DQ(````````````````````````%)+E5:5W&K2=K-IZSU\^
M<R<7W/A[2?K-K:>M[JQ%?W`$;3$DQ(````````````````````````'&Y>+D
MGU7G'(YLR1JLC0.C6^!MUI\LNG<^V>Y#U6U-6WH$;S$D1(`SYOE,J[9-![7R
M]=)^>7FB-YJW(^^#S65XZG<SZ!P.=A?>'BF,V>A4;LL3+OY1KG#NWU-3+17?
MS_?SJ9S/H7LO/ZRVZ9SS9[C_`%/'3K?,-(>=WN:]1M*`7JH>A]_#1WGUVB3:
MZ_*/J'.-L..=6S#Z/0]0.;7W[@JW9=!]/OUM/5]T,]KY3;?52QR7KL\9/=1Y
MUQN5C^D]_+5GF'0Y5UF>,I>G\\A3>8,[5_;:8<[NN-W7.:\_[X=[:7<;QTFU
M@1M,23$@#(SJW-(MVN-)NMV>NW)N@X0=RY1<*GV"K%GKE^Z)=/5^WCY8CP2S
M2Z/2+`:+?ZW\HO\`E[TOGUW*9;95U>RQ>[!RW5CF'0_YZ>]\6WAXAV#"OMG(
M=ZN&]AL3H-UA_P!GY5^_Y^]I..]0AG<:W'OK7+Y9U.U]#[^&Y'%^L_>`HO=J
MCXOOWO;1K.,B.J\TT-H5UFK3[88)=SXY<ZG6RK%FKM]:/<+HT^TC*7I_/(2W
MF#W&OR;EU*T5,M->T?YY<>PQ,OJ,;U`C:8DF)`&1?5N:7AIENG#2;?HL?VPF
M[ARO6+E=^Q4[%RW^@G@_8Z=6VL>5'@^E2;3H+>5.SV*T&YSOO]$D37[/\_U\
M1GL<"_%&M]!+U3\TNBT/3_FU_N53[/7JP:>GMMJOM_'[L/7]];^J6>F=OJ<G
M:W9XE]FY+_5C^7_T5]X"B]VJ-=;'AVRJEBG719^:?1.>S1JK#)^MV5CZ[L\2
M.R\CUPY5TOWGA[2WJMA\@REZ?SR#]_@<S]X[Z\9UT>]U[Y1T,`"-IB28D`0!
MO=/*VKV'4XV0*NV;26BK.[@W=:KW'EZ_N\_KY1]95"ME80LQ7;'X)\ZW6&O]
M[A;"XU1LW.>_AP>=B<!GXDD:[-ZG%]X'WNJM35]_]BJ=GT%@=%MXYV&#..EV
MU1[57+<56Q_((OV6!46V5?YA:*LV3TOOY5WW^@%Q:E;(<VVJM-6;!\@`REZ?
MSR$-]KIYKVXNC4+)D#U;FN_O#.Q``1O,21$@````````````````````````
M#*7I_/(.WV'/U=V6E//+MF-TBAZN\OZ&`!&TQ),2`(H.Z(>F>UB(U^OJ3?GY
MCZ9D:((XF9D@CA/=G&1'O$^F1VTS'1[$ZZ([LA(ZLXTZ&7+IGJ(XD^I'<SU,
M1\GJI>YAXIG\B/+#UWU/2_,1E]387YC]P``/2>WEC]UGFG%;#SEO2[#1SG]T
MEK5;```1M,23$@"HQT\N/)43P$3W+YC69[V/GE_J>N^473]2S'SWI2LL,0G,
MWHB(13&/T[N$ZQ%")F:T1N2K#T*;8(JR?,O00D4AN9FR(_,1U]?751'D/SS/
M8?/S5V?J],?/4@``HK=JE0F]UC]/S]_)?:BVZ\%*L8``C>8DB)``````````
M````````````````````$;3$DQ(``````````````````````````````C:8
MDF)``````````````````````````````'(HZY(`````````````````````
M````````````````````````````````````````````````````````````
M``````'_V@`(`0$``04"_P"%%'+(._/SCZDY^<?4G.>>)N\0F'AYQB%@3SDZ
M/,Y9F78:`'_.,$H3-..EU)#.(Q'VN!':DJ[7'U)SF]1YCD:'$E$8Q&V'6[31
M#"D:C\E1UQ3C?6I=P\P9]"@):L<DT`%[MD>UQ]2<C/.0I/`109UQ*N0?FWB@
MK'ADK.B>:LK3B&3+S-Q1T=E[.<*O@LO"G49S!*'>'03$,G=YA!<P2AWAT&8\
MF\0LE"\V<4%8M<)VY,&>9_)8"W`3WB3=0=<[Y:B!$%G3)/V2<NIK'#\6Y\E+
MS,JRWG:2Q^8XY>W"1PBLXY3<(*AA'+#W,G"IZ[FL$,@'$B^=_)J)K)YJRE,(
M3+M/TV9BE+Q#8-AN5/,S@NS/>0Y/`!X:YEO42V9JRQ.(7,O-G%!1>8LX0N^%
MRP";1O9Q6^G/F4M'X>*=3.[FN%S25S.N)YB[NEF(Y&A+G?:X^I.1Q6[A&>)?
MRY'@>*?4TZN)!:T?)WW08]K+>=6&;1C`\8<8MCWB(]J^'KVLXB/:W&N==<=Q
MO7BQUZ&HWO)LXK/!<3^VK\S-T@:.&4I4"=Y0]NTXV1;CX/)C<KBJYB*<X-AS
MVP)(1$'AMI.8\TY<!+QAE9M/&=&_*WMOC/&`F1L>X9RL;$'#B6]PK?V[.(SV
MMX<?:W9Q7;GC?V_V<2*FB.3?N?Q]66\[1V;Q?`D<<HWCS9Q6^G.K7O0PM)V.
M+I2/)<>=F"-1P&'0R40B+S.UG9FM@;]KCZDY'%;N&-6IK5Q_HSM&FM<1=MM^
M5"<8X_*'01*P1DUO/#=`N(CVKX>O:SB(]K<)3S&\<A7\M82J*S",S`3BL\%Q
MYF''#+!IOQ&0\!IX988YAUE#V[P='!I;AW5]E`S%F",(0[!6&_;#B/G'<$6B
MF#,JZ-#[@3+)H'#1,]7%ARM[;\*WI?-.'T9P$ZOD@=C[?V[.(SVMPIE6!1.`
M_P`]8HJ+R^/3,'BNW.%9IQHTP_\`GK%%,+\TR=JXC;;;\H_QACN@H#"6Y7;Q
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M$P+8MF@D:E8+Q(6#(,$?NNOTUU3QFTN+%!7]C[3+\=@20,4U59`-/%TT<8Y)
M19+)\9Y3@S\2WY";78MF/UE,T<:F4<DTJDT1CLGB\G!5D<9E$(9G@8AU@KVO
M)\D-#@]Q#(;6LZMC"T/*,N(#?(U-F-M>WB:*0B]U.@38XM$4MCAB+6QHN`S-
MRL^Q233"+H1;B9&1\N<3U>7.)^L20J8M6O*<?4G/SCZDY^<?4G/Q0*R[O_3'
M_]H`"`$"``$%`OZ^,@:1A5S*7\Z3:NK;8U%J7=R&U<SN&E(!D+J'6?+ISNBN
ML/='BR2%J=R%QZ[T<:%?S4;SK="!C[^L'^`R`#G77A1U._LL;H^T6PEG:PBP
M^SQJK&EE,T-$O"(:1DBS749(0UI&2+-6;F$:_LL;IRL"379`1SE+P8\E?W(U
MEZ&A+`K!)6+%N;$,B)34R#KB'HV#F4RMEANKRUHAV4"E8N6='D>HUTUTU9VP
M4P7:TC)%FO`J09NQD`'.N+3M1*V,[6&8)V6-U8TLQE&"WAD;(OO&NG33]25O
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MEG=M0[TT4$D]L?\`$WEK-*.[B=*)$7#OB_[S&9Q5+[B=*705&5C_`(;WD?5Y
MQBFFV+[QTZ:40,V7KIM+,31&I%A/P@G`@#596Y=78*[%!H4$>0!<66H:J*4H
M&L42H8L*4J&MYC<*\QN%&GKGW!."X%WF-PI9]<5K==>FD5;D%3#5CE-'8NT,
M0Q4)5=:\A89V*$0V+.Q2XJ*MR"IIZY]]#/)HJ.T0I4-;S&X5YC<*,-6.4"<2
M`*\QN%>8W"BB5"UQ'8H-'DQ?>.C6G[]&TB\8QVWOGJ+[Q3]25^B:K@_I$(\\
MIIWJWL(RP:UOR*:.B-YE+A$CV?A?^OQ73\)C)&$)U*CEVO:8W7:8W3J:*K_;
MM__:``@!`P`!!0+^OCL6H&-8\"_*JX()ZWN8J=O?(56.X%VJQ2*-@MW3KSNJ
MBDMH^C#HHZ?0;$$5Z[O!Z2F4->T&^\4H7_%7X#P:L%986^*6=H?Z#N7N'=CR
M1%>O?ZO<G82A2;"T'(A041M(4*#<B%!0T3WHBSM#_0-Q5Z+P:L$DF6^*6=[N
M(MPI21:12ER0S:]+KE4YO*HY(2MRXM.Q]P=C4XJDWT4I<D,"_7W+4Z."XB^U
MR(O%$;U[R0]CN:L%8*I<J-L=7(H0GM#_`%<YNHE#$6%([)%N^G3U#/T4I=\E
M@I1!52!/JUV];0E7X$D^D,^IHCV2!*^ZG^[2PGO\&G%X1+0:1[Q@GOPYC\-?
M/#6YX3$&\Q)59=\]DDW=NW%5.Q5-AN^0P_<M$.@&PVS4#J=5`VW<-==+=!>E
MS=7*S4!QLNTOM/W)N;TS@&MPO%O?M[VOGAS/X;LD?T@-RV/VORG=_@TY.Z)0
M[.@H.%LD6[_Y=0V+I#Z*%I+(HH6BC+"H$U998G;\"2?2`LL[%U=FQ]_,O4$.
M[2W35F<++[5+7OPYD\->_#6@L)(/M[;2*R2]LDW<%P#3$,>Q4;6$52VC]R:$
M="&SKB+4W-#09H;=P>R^SC#,[CHFNS.*EC$3K>B?N4<W5T;+3+%2%U5-KYX<
MTF"I@=O"I-5-;21_2#-$M$[>%5E]JEK[^;AV$.K11K.1(MW_`/!%=PL0O=G4
M6D>H40^$6"B;HDG:BGL)`0*OHH-`RP<>T9,@=,I(8=,5(D=,I+N`"NX`*%$2
M#3+"1-M[@`I%G`1V*IVJIBBI")ZMPVI1(R9:2*5J"2[<.2ML2;AD2%4[5DQ`
MT0K*(:Q"5=I(Z927<`%=P`4*(D&F6$B;IW`!7<`%(HVH)$MHY2O)D6[_`)=2
MST>C:N(U;MSU(MWTNZ$&:E;?G3`9;T%>>;K[;+7DA(M&[6^Q)O4M%I$I!?7X
MNOP.G\7T_">!R"1[;9%;;_L=?['0")5NG]NO_]H`"`$"`@8_`O\`'RS-A8T5
MIE1L"[6*X.[V*U_2CO$86Y#1.:T7;N&FKQY%BNO[O8NZR[.XNM&&S`R=OJN;
MASC*%&ZC0XAU:8L#R/KBU`XM=P*03O<X!N^>%0>_D^)G3C`XM)F.+PM7G2<J
M_..TBX<?$4W^XW4_G1BVTY1OMXU!+BKM/B$]/T+Q/7N@(QO?1X^\5YGXBBVY
MFL&"G(C/>`;0<=_>P+S.<]2LW20V\_04Z[OWN<)L$VH0="=!#J`#0A!-J$'0
MMG.XM?G*\S\10%Q-8K/.GMGKW0$8Y'T>/O%5N<N'.'<V-;*7B.51Q2:CG`)T
MUUK;;AQ[V_N":]@VG8L.\I(8]1KMQTEX_P"NT<Z9>+KY+OV'+N1PR:CG45JY
M5VPWJX^U4.-/EF!M@Y>#T!!-J$%&"#4LCG&Z\7BO=IOJ2)FHUY'/NF:\`V@X
M[Z\S\15BZ2':9Z\Q3KN_&.<9=V7P#2KO[^3XB/OC[+4UF4@)MU8QA!AD))'>
MJT8#5/N[L33S%0W=]+8MX.`NP?0RY@GS[:EIU=7M1?ML0^S_`+MQS1C+W:`L
M<?*>I?,S.;@K@"+HL+&@"N5,S.T)^9NA-S.T+;F2S@I2S7I7G_A_W)T>0D*7
MPA3>,H2QFCP5'+OAVD*'W@1N,FJZ.HYZ\R^1IZ_X<O(H_P"WQ:@C)/%0-4WC
M0:W6*%V;Y[Q3EUCT)]PDUVBG%ZIXD8W:P-%#[P*.N&!S,(XSA7_T+GA)%33U
MN$<.E2>(Z/0;X7:$?`W1NRYATJ;WCM.ZX??.A8X^4]2^9F<W`#@")CPM:*;L
MG@&E7>O\>3XB+8!:<)C[+4R2\TCA#A4EPZU\Q2EVV$@9PT;A*/R[K-<:,LI+
MGGZ&7,%,`XTVAW^%:SN7<?XG:`@[:OP<*K$ZS-TY#P(QR"CPF9G:$_,W0FYG
M:%M+L'&.R-]:K_WNU`7EMESE+X0I)(XZL<_!B7]4+$0/&<W6FW./&TU/4H?>
M!13MQM;UU0_N?K;/'O4RI]X/K-/)@HIO&OF7^7'[78BR6,R6<%:`\E52.,LK
MOT"%\9J28\XZPH?>!1^#I6QF_P"L?P]F5/?=]23O8,6+&/0;X7:$9H&5CLMW
MQD7E\XZUL[P++B*J7,.E22,C[CGDXQE7E\XZT89A20?ZIWB.A>=)RJCY7D9_
M0D\`TJ#W\GQ%)-?S0VZ#"1B`7].:N&1V)?*7C"8X)*.^T"WHQ?1N,%GO94Z9
M^NXUW3=XK-@G?&7<+H#CWCB6VE#;=-Y">*EL949Y:6SD0GAI;&5?I\G:OT^3
MM0?/2K13`G.@I5V5?I\G:K-JR/NX.?&JG&FS,UVFJVLU+5*8%\E@V5*<-%MH
M:6Z4PITTFNXK806`W-AW?E);)CH-[#@39F:[35!\]*@4P;FP90Q\.'T-O#2V
M,J_3Y.U?I\G:A+-2T!3`G&"SWLJ_3Y.U?I\G:C>):6S3%P"B,$-FP<H]*3P#
M2H*']>3XF=?SC[#4R1GVJ',4S+L)='UW+X!I5WQ^?)\1'WQ]AJ:\X@X%;.[L
M(>12IIB.3ZZ$<8J\J0WFC06Y1ESJ(UC[DTE:EN#O\*=\O1U)LH^RWA6TF;1A
M-,8.@_7;I+R:"Q@57".OA*U8OW"M6/\`<*^6N+&MNX=6HP5-*?Y=O__:``@!
M`P(&/P+_`!\M1ZQ-$+9GMY^U?^P19!QY15-<XS]X9>U8Y^7M6%TPXT):S.A/
MK`X$\5);44KD+0?KBS*T.'"F&%C6FWO!2^Z;\,("9H<!$,?B<J[)G(CLQ8D3
MO[?>/*?W3P9"I(OL6!^$?0M=#OH2,95I'`O+T(&\BDV&O*F,@]9:FA!]ZC_*
M_;(A.S$4Z:+6%-*;-)KFNE.FBUQ32MI$VK.)>7H5;V*2537PXR4)&,JPYE_6
M1]S-3G6UBQ:$^5NLUI*$,^J[3N;&[TH,>=,E?K$;C6P^>XI]WO."=NX^5FLU
MI*L7O4._DW&1Q8B/0=-'K"B9-)KD;K71;_8F2.UG-!W1%#2A"\O0@Z]Q_EYN
ME":/$=V/QJ6G\)OPPOY0]IR+\@JG7ASG"DK``,5"4R\#?Z%).P&PX,PTQD##
M]"S.>A,BV;C9:!C5G9NP\.Y"XX@O7Y.U?+W=KB2@R37.%/XM*9QZ2G\6E;%S
M'$U7E.Y4'Y0F>)1>`(QR86%2PC4IH4O@*;?8]=LF'F7SGW>?_527^37<_M*B
M\*J<2-Y=78QXN+%^V=,OS-1QP]*#FXB%+X"G[TP?@*^0ON"F(E1YNOT'9QI4
M6;IW6<?0HO=MT;K'?='2O7Y.U;"!KJD[Z#9,#B:[L?C4M,6R;\,(.F-&F,>T
MY.;=^^\BF`'?0@K^?M6%W!5V`(;9M:*RP4;]"S.>A18!Y8T+$-R$'%VJAC93
M,J2"MW<>;K0>S"TI_%I3./24_BTH-F+;=<BUF\BM0FK4SQ*.-SQ:#`BV'OR\
MR?>Y1A?B4O@*?"[$X]`1_M>];_8)L`]4CI4?A6R;YCT'1R!MK#2IZEWY`ZF]
M4]2-UD\R/0I?`4_Q]"VD>"\#GX$R*?7CP>@[.-*C8][0X!>8U6HB"$SCZ%&U
MTC;08-"\QJML-6I@.0=*\IG(JL8P'-Z$?C4ONF_#"9%<A7NU/*56\,[IRA?-
M08!)*RHR$.[?HP)JT"$3-5HINMDEK:;N6)@MDPN+.%&&74*$,6H$89=0KU^7
ML7K\O8ME#6S5!DU:!>OR]BJ&5/#AW#$[5<*+9Q5LU7S>':\RV4M;-4(F:H0G
MEM6AR;IO,=0\\B,3M5PHBR&M"=S;/!M\'H&&74*]?E[%ZW+V+90ULU0;-6@7
MK<O8O6Y>Q"%FHU"66MH>E'XU+CKLF_#"_E#VG)['?9T)P_\`-'[7UW'XU*,'
MEM^&%_*'M.3F#&05M)W5;6H`KCX?KJV\T:$QMW-IP=D/4GLH_O1MQ-/\,!-^
M8JVL>0_:*I$:D<!Z?KL1W?";2#1B'AZU_P`>M?\`'K6VOAK,12F3_+M__]H`
M"`$!`08_`O\`L5406-'LSQ63S.<CMQ%ACC.%MJCD:F:F7/-%_#_&_D][\3!_
M#_&_S%[\3!_"@CT3FQ["WGI6#GJOPE>B@+(?(`-S7#(96@T)J][JS\4Q%2?,
M^],LYD4'>D!=A:$DIH6]R\*=ZW(;S(JMZ)TPZ)E][4]!UM5:%D0;E2@`"VKA
M60$D.[CX%PP&\[5TS:N73%-,D3?O2TW<$EA'8.]8]PA#F'A*PJ]XUNXI(ZKT
MSZ8_GGWK_KH7S_&F3=_>G`;_`+4U@<[/<RB2C$_\N*^_2V^\:[X[9HB1[RDO
M^XB#DZ=:P9K"RQ2(,QK?R2M3/')([9]E81(TRFD0'6LETN6&);<9I[1HGF=F
MO\;)<N7DS]9QO\Q>_$P?PH*+?54&VCA+OB#/CLD#&;2YFZQI$5$?H>J9^WCC
MIJ&AJZ@TFUEB.2!$%&>838#WH,BC1-34?UQS[5GUX#PG+(;7:?[CKU570Y&G
M_29BK%?T\"W'$X3&?&9/CLD-`\O*+]".&C\T:KT8F?N8R7A7'>J9?U<%/'W$
MP?T'#3C-L@G]I(@D*L!3>+$F07N(-PG+T7;T.1,6WW:\NCD]!<HDNXS?UY";
M;8-D0K`P;N.J]&EC%TJCTRU"=GUR3'/*G>WUK7<+C;FG3N;'#ZZ*A-/D4B1<
M_6<;^3WOQ,'UO'"\;D1`.LI=@*5W4-DM',C@"06A'N;H5'/7W<1;"!1,E0IH
M!R8LD5)`VSQS-1XBLSF(NE[%SQ^S7_`Z_P">XKI/-8W9\C>Z7WL?8'&T-;+,
MV-\")Y&-U1D:O1>N*^BXU(@,C2Z>))0,BO%**^9(F2(_FE(]N2.T-3+'[.#_
M`%73_P!I8!*YCQF)Z/*1!_RJM[0)7NSR"RQKY)PA.[3T1R*J^QBNY)"&Z.V8
MTC)$1[D>^',CO44F,][<D=I>F;5\K%1<65]1$`*QC2:T8GR`-DBT29P0%S$Y
M41<QO7W,5E]>$"6QE2+%A7QP-C"TQYQP"1!-543(;$]W%A>T9`"L8\JN$-\@
M"21:)$L82YB<J(JJQV/25#6`M(.\2/W4:DA;6\++<'\)*8N;-6/V:_X'7_/<
M2#_>%"["Y;9'&$/:AB9P4&%1/VPE*U<R*[KGCCTGC9X@"6,^9'E+*B,EHHPQ
MF$'H1[FZ%U+B-95U&R9`FA;)BR14<%1G`],V$9G,1V3D]K#6<WXF$@2*C6I*
MKI5(1Z^.4>:Q3PBNR3PTKAES3/>B(_8FPCZ4E5\M&(Y\<S47JWKYCT\TC>J8
MY)<5SALG5M/-F1'E&A1M.`2O&KQ+DCVYIX8K:3EIH)ZZY7T='?$@,BDC61E3
MLB.5CG:Q&>FTJ+X:\_)ZDNBXA+@LAU`61;!TJ`.6K[;-SY#!O>YJHR,QS6+_
M``T=CC=Y:O&2PLZYDF6\(D")Q7$(WS!-548F3?4J*GC9`_:6UD-D9&C-EC#5
MLU!7,2JU-V5+5K6>X[%WQOEO;MO:[5+C.!';#UQPE2).AE`CE1)$*3DO3JJ.
M7_)]3DMU6N&R?65$R9$>4:%&TX1JYBO&N2/;GY,!B\\+")2S=(._APFQ'U9W
M.31*.C'.WH2YY$\K$\Y/!4PPHGM((K&D&0;D>P@WIJ8]CFYHYCFKFBXHJ?C\
MF"&#/KP2)#9,`<HBE)8NCN5I'/:K4VD\,)[B>K.O:(H`V()E:$;Y`&R1;<F6
M,)443E1%56._%B'>WQ0&L33[8#WQH[8PMJ)/,`*;355$5!LZ^SZO&B<;/$`Z
MSDV`Y?=PV2]38X!/%H1[FZ/.?CC5O/<Q\VSHZR=+<-B"&Z1*B",56#3-&-5[
MO#R>K%H^.28`XDBIAR4%(KARBNE'D'%T(][>CM"9)C]FE_4=?\]P"9S+B\=:
MTST$G=UCJ\9"+FNV.PA'.()W-3HCFNSR\,5O(JY',%.$N['>Y'$ARQ+HE0RJ
MB(CG`*BIG^4G7U>+?3,WZM?CG^EC'-7@/"=2N8QRL3[#KU;J:JL_%B*GL<%@
M?X^4<BQ8V&WN]A!ES=K/3N=K'(?;U9+IUZ,L_)BTY;8<@N8A8W.N#U\.IKIC
MH](*NN++9EP7P]"]PSMT1-3EU*O7RXH^2Q<V/N(*A*OL3:8@U$1O3IF`[?\`
M1QS7D<%DQT">/B4=9DF,Z.TUI6TY(UJ$6?O]@FC/_.]9QO\`,7OQ,'UO#/E]
MM^B1\4M#]CN[]#UL2N[GTYM=QV@6AWMKT63;W-.>6I<L087V)V^\F18FYZ>U
M;?<G8'7I]$-U:->>6?J44A^>B/1U9WZ??:`VTHCM/AUR;C^9\D_H,/\`M#!>
M+T538YSI$,A9EDR.+9[<Z%1D6.$L@A3D5J)GFW+-<0HUJ(T:=839ML2$=BC-
M#;*<P80E&[JPBB`CU3^%BZ^64OUI%Q1_*KGZTE8M_EU/]8!Q]GOLSZ6_E\J=
MW?I7L_YUH^#V?1\GWFCQU=<+_<;_`.P?_#XKK';V>_@1)NUJU[7=1QGV]>3=
M6C7EGDF>.(?2ME^A#QPK]WX'Q>)]1:Q12X4V,410E:BIYS%1KV+EF,HUZM<G
M5JXY'3>^%(J9"/5%7+<JK)C`D7R+YAWI^/',_P!W;/\`1W8@\[K6E9*J^5R*
MV=(&O\W9M0Y-1*TY=-$S4Q7>VU,?]0'F;\#2N>=KF]?3@6]HZ&X;4\7VGF]/
MR5S\,<F^\6XWRSIG*8%?$DOZ,D2)BRYEU(R_*<A-#$\B9KCA?T,/XXV)$J21
M!1XP"R#E=GI&$+%(4CLNN3&-5<2.4RAG+QZ@D)/CYIH&"+7F7[.PG=,M<@[=
M][?%V3L4WWB5@5]'VLIL\P@JHD)+`UH;N"]V2HGI&(_5X=5<N(-E#=KBSX<>
M;'=[(9(FE'G[>EW7'-?W>L?B5QR;9T1N155YJIYKNC":ZZ(XE?,R3-\4VGS?
M]F]=7LX_Z<<Z0L$,>1V%:>=YA*.6KW+Z,GJO7LC/(FR_/2+_`#%3+BWT1$^M
MR83W$]6T^D:;ZP%BM^EK_P"M9'J\+^6V_P"C1\<*_=>D^KP>K5F=GI#2U179
M>.D<^2]<O;R;C^9<D_H,/^T,%XS15=CN39,0I9=D.,)`MC&0J-C!$:00D@CD
M1,_-R3V<0`VH21I5E+EV_:E1S"Q@2]M(["C<B*PKQ"1ZIY-7J\6^F9OU:_'/
MW!&5[6<!X2I7,#K:U/L,OOG[PM'3VG8K9-].]'`F\*AABE)'EE&8H.2W[C,8
MZ.`J:AM(W-/;Q>5O%G6');J94SXL&OK*BU(ICR([H[=4@D,<431J7-RN>G3$
M;C+Y8)7*@<YX%9\K'%(APULB?>@'7UBG:B-4\>+&S>WKDYR^14Q$9R6I#:-@
M*9T/=>8:A60C&FTJ$@U\]!I_@Q'JJ>#'KJ^*W2"+&8C!M_RG+Y7D>O57+FYR
M^/K.-_F+WXF#ZWAGTA;?HD?'#"%K:\A'\;J'/>^'&<]SEACS<YRBS<Y?+A%2
MKKD5%145(49%14ZHJ+M]%1?4XZQ[4>Q]13L>UW5KF.N)*.:Y/*CD7!XS^(T+
M&'$0+GAKHPC,0C5;J"5@T<,C<\T<G@N&LN:P5Q2N<JQCR8L8I95.8F0+.`0H
MW]O80'?QB-TJKFJWP5,1;&ND"EP9H!28LH+D>,X2MU,(U4]E%_%BZ^64WUI&
MQ1_*KGZUE8M_EU/]8!QZ.Y585<:T]+6!]J77OD%[<NULNW6Q39M5$Z=>F/ZX
MH?U07^S\2)/%[(-E$@F;#.X`C"8`NTTC0Z2B%_JG)X=,<0^E;+]"'CB]59\F
MC19]?31(TR.Z/-5X3B9D0:JR,YJJU?87!Q\4D/O[B2`@XRM`8%?#<1CFI(F%
MDB&I-GQVFHJN7QR3KBVYM9@4`;:.E?4;PW,/)$LA)4R>UJHFF*<C6M8OY>2J
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MYK^[UC\2N.4?O`+ZMC8==T@@@Y7"$[+P$.YC,34L63H$Y7SFM9E'>JIEGI7I
MX4,'D;SOF\;V:0?>,<RP$`-AN)%G*_SR%BO<K$5WG:4R7/+">XGJVGTC3?6`
ML0::_OQ5]D*PN#$C/C32*T<FP,8#M88Y!KK$Y%\<?M9'_H5E\SP:QXW8LLH8
M)+H93,$<2,D,8,CAZ3C$[-&%1?#+KCA?RVW_`$6/CB]7/Y.`$ZOH:J'+`L2P
M<H9,>$$1A*YD5S%T$:J=%RQ^UD?^A67S/$6[HY;9U7-W>VE,:1C2;!R1C>85
MC")H.%S>J>3%.QR(YKJBH:YJ^#FNL9".:OM*BX_8OCGZKC?^C`SP>*4$8P2(
M411U<1"#(WWI&/VE<U[5\%]9Q;Z:F_5K\<^74-NWP'A*^<DG4[^XZKYFRQ1^
M3\M4QQ2E^[R*LZ.+CY;*<`55!GD"65>6@D*XLKSFM)L9(B>Q@3>20!Q!27/8
MP%QQEL,$M&9;XA&!VZ.\QW56N7+/"\PXTPL!G)^?<%2XHBF63Z'NJ_D;-]@)
M#D1[HLL,EI6(NK+5X^1/6\;^3WOQ,'UM<+D"V"-JRG-&["4V,NJ2Q@R;FH)M
M:9,Z>&*VE@[O9U4./!B[[]PVQ&&@Q[CT:W6_2G5<D]6'R*Y=:I8001HP4AS6
M`C[<60^4/6-8Y%5VX_KU\/4BQ.01S*L(^_%F0R,CS@YID4+)+A%5(Y^FMG@N
ME/8QZ#J)5F>N:<AP"LY39:Q5-YQ!1GH$*L`Y_G:>J(Y5]G$GCURLI($HD<I.
MS,@#ZHIV2!Z2*,B(FMB9]/#$;CU-W*P(KY!!=X9#GU23OD$U$1@T5-9%RZ>&
M#\?N5E)`DECE)V9D`?5&*TP])%&1$36WKTQ[_D?ZU%\RQ[_D?ZV%\RQ.@4"S
MU!83$FG[^2V2_>0+`?!N:(.EF@:=/9Q7QN0+/0=8<TB-V$EL9VX<:"?N*X)M
M3=+?:Q[_`)'^MA?,L))]#$MRM]YZ<E/L`M]OM,A1'K_GL=AHA-:,8VM8,;&H
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M*UB&A2MA^T;9,W2_;(K7Z'Y>7)<3H%`L]06$MLP_?R6R7[S0L`FAS0ATLT,\
M/9]3[16$>=%LG;*G=62APQ2R@?J;)DB[<FY)7HCG^+FHF>,O5-Q^Z64D`YHY
MW]F9`'UQ2H8>1'#*B)K;UZ8]_P`C_6POF6/?\C_6P_F6)%30K-6+)FOGD[^0
MDDN^00A+I>T0LF:`ITRQ6CY`MBC:HD@L;L)38V;I+&C)NZ@FU)DQ,O#'O^1_
MK8?S+'O^1_K8?S+$'CM0LE:^O[C8[LJ'D?RJ4:8365&#1WPLAV73PQ'Y!=.M
M4GQ@1XX^SFLC@VXIG''J&L<JJ[6_KU\/7<6^F9OU:_'/]UA'+]@>$[;F>]8O
MV&7W_P#(Y'3/^$S$;]Q:_P#_`$_(L<AKYHVKLUTFPAER\^+.@!?)C'$OY+D<
M/2OLM54Q<LS70S[Q?NS(C>NEKB6V3U1/!%=H;Z[C?R>]^)@_A7BWTS-^K7XY
M_P!(R_W`X3U,S4]O]QUZB7KI_P#'$3]QH7_ZGD.+2O$YC"SJZ=#&\F>VTDF,
M4+'/THKM".?URQ'LN37T65!@'BSX]33FGI&FV,-VN)(L=\49KF02>>Q$1V;O
M83Q];QOY/>_$P?6^E),.?9O))'%BUE4,1K*:9[7E(V(`I0H9010D*Y$7/0Q<
M0[6MD#EP+".&7$DB<CAF`=B/&]J^XO5/%%Z8MOLYQVQO8%1-D5K[0,RKAQ)\
M^'YLZ-5][+$27VDCX%Q,F"4J*B.7+"\BRDUL,#)JV(K:.^#*JB5CBLLP3Q$_
MBWP2`>CE17,7+-JJW)<)R<7#.1EX^HN\9(9Z.])DJ-?2V'1++2Q='?%^'0>7
M<*/_`%>?3'VED$.:N>"(6(V)'*:98/L5$RNBPH>E#%ESBG8P;,D74[KEUQ73
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MVJF%N"UUA;?RV!`#7U;0/G29%A*'%"P#9)XXG+J)GEJS7R9KB'RV(\EI53YE
M3!CN@[:DW[:SCU+6E:8@ME\.7(R.QV3QJUR9:DRP%U?0S+S6I-YL2761.V1C
M45KG^DI<1";G5$T9^'7%=9Q>*VT*GLQF**RF3*14&T3RB^%BQK(\M%<82MZ-
M7%M04M',N9-"&O?;'9,KH4:*:S$^1%AM69(88TAT5FXN3-"(Y/.SP4Y:JTI9
M,:6>%*K[<#0R!FCJGGA($AHLR(9CD<,PGO8Y%\<\T]2+Q-X)"D.@1&M6OB>C
M(5I,!)EUU+*<Z2DEMG91(A""8@U16IX]4SL+X\.58#@,$[LH.QW<EQI`HPQ`
M[DP`:W$,GOGM3$SFX6RI-?7QR$FPAC8RSB2HY6@F5DF,8@TCV$,ZZ2,<J>'E
M3)5KYSJ^99$M;6KIH4*&Z*PQ)EL3:C(XDL\>.,:.]\JNZ8K*GD/&[?C:71>T
MJ;*8:KF5DJSR5XZI\FLG2^TFR1M<H4*C&E5JM:NK)/4F7$D1I+8R#:*'%VUF
M3Y<@K(\.!#:4@AOES))6C&U7)FYV(MQ!U-&?>$:.51]Q"FQ3$BSH$I!/(QLJ
M%*$X;T153-.G3%_4U'$[>X=QR6"#.DAF4<0+Y,BOCV3&1VS[*.8B;$IJ9Z43
M5B;*B1)D>PK)$F!:T,Q`AM:VSC-U]A*8AGQT<=BM<(B/41!O1R.RQ]K]:PZP
M<"3.F-EO"PU>L'=2?$F:2O"*5",!XR)JR1[<1>7SJNQC@DLJ2+6.[5;$"7$R
M+#CH9$D=OK&LQKGHCUR3/R],5$?LI=G97UDE74UT)8S"R9"`-+.]YYAXT4`(
ML..\CW.?X)DB*O3"4]EQJVJG%AEF1K!SX4^J.@"#8:,LR"<BQ9;=YJM85C-Q
M,].>2X%QNLJYE[;]EZ2G#AEA@C5$%SW"BFLY<LXF!=/*QR!&U'D?H<N6E,\6
M='+KIM)>U3`R2UE@Z(]\FMDN>.-:P#PSR`2X!2B<Q51=3'IDY$7%M75?%+6W
M2GD`BR9@9U)$`Z0:%'G:!,G6,<[D8*2W-=*)G@L]D657&ASIU795T[9[JNL*
MTS@RHQG1BGC$TY(Y'#>YKF.1<\?::JXA>VE"3?+$D0CU1)\Z$"2\"S8E4LYL
MDC"-&I&#7([F_D9],`E#:1K)`1'8TPWA,UA6(1K2A(C2"(B.ZM<F;5]?)LK.
M6"#`AB<>5+D/080B9XN>Y?\`%Y57ICCP>+EFVY(MC)E':"GN&(R.6`Y@RZI$
M$37->YR999XY7$="Y"Q]YP?AD6&D.HNY,>48?#6Q2"*2$K`,49BHUVXCLO\`
M#BJ=R=MA4I)X6``=VHMBN4P>37A7B<V-#.\;VB*UWG(F:+@U?2V2RIL>,DPL
M<D&QA$;%4J`0R).B1M;-U<NF?7U_&_S%[\3!];Z:#.C<=K>*0^RXT677"O/2
M<^W"Q]S<-A^DHHX2Q0M;$"YZ;BHIO!KDSNN.VD@5E4#FNM*"T!%#7L05P63+
MLJA(`I)UBBK+!SE"GALD1,^F)W%R<4LN00*J382..VU+(J&I9U]A,D6`HD\%
ME9PRQ;2&62X1'Y*,B(CT7JJ8LZWDPZ^HM^05MQ#>&N5TR/4!LPR`0PE(16ML
M)4,!6[SFZ1D(BZ?-PV#]@#GY2!!UC)#+*I'Q0YV?R=MSW*S_`$H&G7+>47;K
M(1OF(BKUQ7]FM>?DU+-I+Z.)[CQ:F?:TYA2#0U=\(:/$FY/8QRZMO-JKGE@?
M&HG#K#CWIQ&`O+:]DTQX=-7(5%G=J&NLI9[.P.)FB.FE@\W:GJF66..6=+'2
MPG<3Y%!ODJE(,+[6**-+KIL./(,080S.TGN()7JC%(Q&KDBYXX>%./V%)44%
MP/E%E96SZW<*>%%/'@U$"-`L9KWE.>:KBD?I8P8^F:JF.)3^R9*IH=5RN%:N
M*H'!;Z4CUX@`+'([4<<I!/141KD]G%+!C?\`N'`:R%>GI9)Y*.G\;?/9""WC
M#T*_>FU0T%KADZO$S,3NC6+CDE14Q^[L9T!!18VX(6Z3N`OT[AGC$WS6KXJF
M)IJ>`EE<QZTBUU>\PP,E6#091@E.][&#$I\M:Y^]SQ%'#Y14S+JGLG<QAA^S
MC89)W+-\MC*0MRVVWV"M3&)%(]69=L32K<L<;<&L(">WDG#;B?7$/&W*\,*V
MA3;)CS(78,Z$-CO>.77I\W/##\,!W5=R#DW')W*J%\I!!C'K[R%8EY54I).T
M`)3A1-N8%F7<MTORUM741$ZJK7Y?C1<L<>J;:,L.QAQCLDQE((JB<^;**U-P
M+R"=F,B+T5<2Y]KP*7;"[.,VIY+Q:Z?662A$Q=VLO0)=4A"D#(<YP'HI6;;\
MO-5%Q<DOO2,>),N32./5%S:)=V]/4[(1]O.M$(?=WY0WE&+=-L#>C-:Y8EGC
MQG39`8QR@AC>P3Y9AB<\49A2JT8W'>B-17*C4SZXGML.3U,"ZO[!O+K`#.-I
M*)`Y2A`S8+077IA#[=,2.*,)[69($>2)DN'1Y%+VG)YT:H?-IARHSV@F@LH1
M9K`RM_MW`1`N>Q=>>C+R],<@G\&`R3,Y/$!6\FXZ\PXT:W3<C"!?13&*,,6[
MJHXM*_DR0^:[SFL7'&G559(MY%-RSB]Q)@Q31`R'PZN3N2U"Z;(C1W$:WP17
MIGBAA+QF9Q>CJKRKY#:V-V>J/,F/I)8I\"KJH=9/G:5E2QIO'*YJ#$U4:BJ[
MICCP84F/3T/'$7D*6,F*RU9/Y(CUBUL5:KO8>8ZH"OD(5ZY(96:>J=+L<N1$
MN*+DHUOC6,6`*G]'\F$Z-#E@6N;-EJ\=Q#1I]QJ_QPGYY:DSY_)3A=[=1+ZY
M@6-;+K)-"@2A!Q^M@/8])]O$.)Z2HKDZL\.N.2\COP!@6G++,$U:B.1DAM1!
MKX0ZVNBGF#\R9.?'%N&<WS$>_2W-&YK(X_%A0_\`IIR>S!RSDJK((PP;2"\9
M)M(&(DA'.B<FG!CG*K40:(T[7)\)B;65,;NIA9M"0<=I!!S%#O:V7(5'F>,;
M4%&`YWCY,DQ"#]DX?,H`[`1;&J),2OM!":UVU8T,QY(XQ64,JYY;H5<-51'H
MN*HE-5<GXWQ:#7V+;J-R&_6UBVYI+`I6BKH#[J[)&E0I#5(21J%YGF>=JZ6G
M(*^FD\BIN6Q*L5H.`>"*RI+&D`:-%.,,^5#%,K9\4V3T:_6(K,\E1ZY2>:7-
M82@BPJ5_&Z*JD&B'L)(9$UDZ?;63H1I$<#2/CC8`"/>J(CG.R5V6.<EDR;NF
M+<3`>B+.IO+""\+&T5?%;/%%A3AQE-'EB=_&CS=I]C$:MGUL>MMHI9[)NS(+
M+BV,WNC.==L.<\B80=PY4D*A7;K-:L7PQ;('[M^14O*I!935D<.YDZIH)$\I
M7*EO6D]/@;7PY!';KFOA:VYJBL<OC4Q[>0DNU!6P0V4IOO9,\<8;)9T72S-"
MG1R^">YZ^LJ^,PRSRMNAR9L9DH,9CXPXDE&J7?,$96L.YN2=>O7`8\>;R0,>
M.(80!'?U",$(348,;$W^C&,;DF/ZQY/_`,P5'^^Q_6/)_P#F"H_W^#\HY_=S
M[+DDZ!Z*%!ER`RTJJQDONT&Z0'S22#F1'*B*K6)TZ^OXW^8O?B8/X?XW\GO?
MB8/X?XW^8O?B8/X?J)['#0,`5DPS7*[<<LP<9HMM$:K5R4*YYJG_`'9?_]H`
M"`$!`P$_(?\`XIPA$(4A3S$$D_XR;+RUT\4V+$X&C0P6B002BAB,%P8M.@+@
M[5QQN"+EPFR2\Y`B5F[X:-(K61)=KM=:6;E?4/#SV];!L3$JQ^++=.^HX&3_
M`'"X*/SGRA*Z@BQIP?P++$@>'-RLS#03V(\>_P!05W5@S\'T;086PD4U^6Q1
M]><>9A!/JG$:2E2.F23^+L"O`1T>5M(;#IT*6@X'_"6Z^RCD(!!+A6I.>@IL
M108YZO'!>>W3ZO[<[73K(,7!@:#9-`>N>7/MAUX@P`R.B3H.V&2HOYP<$DU8
ML`@O7`.]PANV\0CS@/3N4MVW@]U%P\5YQNG(]N@N'E.2PF>NQ]NRI'[V/F9Q
M@G#1NL(!ZG.;AP;J7EN%#Z9%Z0C?)43*^IFQ?CVU=UGR@`N]>"62/N3O%FZ7
MO",U-"76O3XR)X'LC::_XF(\J)@F`]H?"#O!Z+>3=:S5E5V)9Y0CLML.3BR5
MA,"80VG>(U:H21-Z%]8"#'X(HIPT`Q'%HYO`=0">K>-6>5'W3Q/L,-)(\$;M
MBK)L(#'V"NV_&->"<;6$2ISC`";A;2;@=/%20`M>.`#X!\(8BLJ$&T`:XT6\
ML,:KJ1E00(C3]!DX7I<BH^CRCC'Y#\`SF)&6^!%>U':S.']1*A>RM(4U8;#I
M$M28(%M5QP%T9'46B0NCW_Q/AJ4?)KK$?/52N=<GG^(<`62F#?NGVPOV3@4"
MA0MILWFR#8QP]=92I&=3`<V3U-9!`\;)&)/H-:Z<UU1'5.Y3[PX,`G2+\,>7
MZ^B_T!8>-NW>`9TN5.R>41N$9=:Y9'4L._#?=L8A@]ZFN2]=G(KAXE:<8`D1
MU8;J.P-3RM3H!L\(G'T\T_!JB;AC^X_^0YOT.LGGC6*ET']AY,[[$J><4)8Z
M/AXNY)<%=`XNAC:0A!_.Y27V2[`<CP\O)NQ_C/\`?F'/=%>R'PP5H]</MOV\
MR*3@[1^KH1ZLHT+N%^B8[@.[]!GG1+1X.H2O9Z=PQU#1#KZ2('!A"+S0FR2@
M^,W6)Z21L!$[<`N^I9L2NIKV9M+V6NX.L'0J7_$^"LU"*(VJ=IVNW$3^=G`E
M@4>G@.R8A*4TJ$ZCCD5E]7='$H"9O+0H>BL@E#(K#RK#+]-N`Q5$$?H/Z:<9
M6ROJ@2V/"_;($QDNPBB('PLRTWFRTN94'IE?PQ]:M#(@!-@T58^^Q.V[9>"^
MV^V?13"NUO!<*!@DV0N#A)RS<J%`T*WU6\@X\%R/'OH65LVZ':C"J^O^C<M;
MEE&F,L'5:MIL44@N;UW#;Q5.X4%3P>"))1U9KOT(!_7C"Q4V.&8!-P$Z>"DD
M@YY-V/H/R;7=?ZP5E%COP))&?<E5;2CU'AQ;$LL$0FP137@2XRN=VPJL(;[,
M(&?M(9ZQGTP0]C[)A$,-YZDB*"(YQ]!%XZ$&\%CWT"^EP'$::;4W8I7K`BD`
M?>Q4!B*S8O)NUINY0F(_XYM2?RVM&(+L.(&FH-`V8O(/3QW,HD(EZ>INGAPY
M@*NL[-*J<C+%"-LVC+O0B5C<BWH>%JR[IC>-]T&J]1,TQQ0%P[MI8NGBE0Q+
ML>CX"Z4/5<N]JM0W$J$A\$.EFM@]6C:=ETF'Y(Y]7"@!`QAB[F3(QIUH/3%V
M:.H<!T+J=<+%3N?8D9M>YP"<IMX#1'4.MXHK?T1G>P[RE9^Q3VLB.:C4,L'!
MP'`]`Q+BB3C_`.-;4UAKH8Y1:#%4H4:T.V1!(8PHA#X/J\)T3KXII.5`E4'`
M@'``?'BMB5X\+@D<SQ8NV`^L8.!UFF[O+.TFP8NFXT?%F[V)"^F&W>(R3I@;
MI]SLWP*FX"$\]OJ,H0FV[L#*FA[?7J#:>OX<]88=J/3?J`9IQ.K;2Z.X!/>'
M^\;&=%<S%'/1/?;@9\G]>,A0R=+22L%G!B4DFI=:0K6I:'^,V"<-GWC?F,T+
M##MM*"8.KO-!11Q'WZ([/?95)]<BI=@=GU0YW9*1!0F.8D:]Y*YB8[G#TNHQ
M&H1MV6BC=ZC1!8HF2P<V"5)22*B,*8I'GO#:2+&W!AJ)#6V.K`=C5QDS86##
M83$1A@3(7)8#%HWD,6720NJ@KG:,K#7G"7"!@=,2NI!\9$VQ$"!`=0C@:?3<
M0I<A:$%H6P(:!,>#63T=))`DT(M+#>'<)TFX;22^TA87_&)XI9S<`89;FL44
M<V#T.9)DCL#0*'N&/$KX:;ITN:%,'I+(D/U9"N^*R%9Z@=P&4:<D"F:#G5H(
M-F5YY$;6,LZ32A2]4I!\(M.HG2Y6,(*B13>^<M4HPHW7V&#0+E?OXWZ<L>IB
MG$Y-:(6`S`[5F!-^)(9.MDC>L\^LJJ"_?`GXA"`)4S(*:OX$2U&H2;1%W(7G
M*"6TZJWP=P;3-AP(V<9/*`;<&X^^CB#P98)3ZSG'CTZ;Y0!4`%0PUW4DBE]*
MU;QCHXC34P15!1-#!X`TEM:1I6F`<F_"$\._\D?40@BP$'/X;1#!^'`.GVB2
MSS6&Q1]A&X\R=`$!I#EJ>-01!#CKZ9AI$0:[R.)*Q&<)+ZZWNW)=<WM=G!!C
M+;!>$CP0>U;3"C^ZW783'*1G8G@.Q-5UBBG$2T[7JH(KQ"6E85R`R"45&ZFU
MG1^3<+,GCAC<P-*@YQ$H\J`("&S]MPHM/O0,$!B]3LC\`0*F#*AAK;`VS=QU
M0^AJKFA;??*ZN4O$-L=]0G!?KN7GYQC3J,3V[>D5Z@I!<6K,*3E&L5,J*X%P
M(W%JQ:#ESO&!I*P0G3J?;KG>N3$T,*,A-'*%,&`[!QCQ!K?9218191P?OW4P
MFGB0@IL<+(_Y+L\1H,X^TK:QF=S00P6V<O-$KK0P17KZUB%1@VR2*ADJ`H_X
M:2I+*K+*MA4;.($Z99ZY:5D($&:S!+,O7O\`\NW(`/V$,1"'7=H-9B*.Y/W2
M[2[B.;"EPDT&1T[ZPOR9[R.X.[[PX^L?1C^GV=E8D%**VP@?]:$"Z#Q9@C9Z
M7T0JRI!LEG_(9YL^,!"`R1)XB!)?^,O_V@`(`0(#`3\A_P"">G^_Z?[1_P#M
M>2/INXY`TV5"ZOLSKVC-BNYK>S.4X6W,/V9_ZC!NT]`?H8\^=0QZ`GJ#E<+4
M8FW/@^CI_M%C<15&=L*JU!&..=>?.X?IQT?AJ7O8%Q]QA;E-D:?L]Z8<+XP*
MGH.G?7?-':5]_H3I])_H01G*XZ),3@3DXSROZ,B82EO1=OK<BPE1&@N/ESU&
M)E$]K3UD*?C&(KQ>YL?/7`87B6<)-X1"2*WD+O!45C3'5&\UR&QXOMGE?T9K
MCZM7D]_C#50HC.7&B+B.A^V;E![`^=!]\1'ZAP.Y_)TRB2DZ:7`(.]:I\GXG
MA5)["/3]]OM,M&2%WX!\Z&F7G]@Y]S*$.AK=I4/8>=^%2$JFM.&1\VJGL=NS
M[8B-`Q,3M6$1J''GQ/56],X*8&"%=MW1\2T41(YO]9QUBZZ$'C&IJB"`.>5_
M1@S";U:>L*>;FSE=/V/D?0`&Q1S<%E;5F\]V9NC:)L>PWG/.L\O<<@15PWG-
M]]_;Z.GT^3]W$HFT;2MEFY<UL_$O@7@@??PJ`+31M;2;4->F\<0@KB-K]V?&
M>==^>4=N>3=V4U<^@>L_K/79;,N\[QF>3=WP$CH)IYX],Z23_-^C/(>^/80E
MWV#^#]\D/+3W;Q(5!CL0/WGYS]&!E4`.Z\8D$+GJC\1IVUC%]<=[;^3KXSG5
M2]QF>0=\_P#$#0]3KW-9KW,>A^IU_ESYMVX\^/F'=GDO;]"7G7=XL;RC^'A0
M*1B;6TFU#6(^"6=4M_+/CZ*)!A9_9Z.;O2,0@RM3G`+9@L!O&S9T,:E*LZ2C
M'LKKT#*IU.DW..??.3&2^?Q]'3Z?)^[A0/<N[UR^M7N_OP:HTY0055VD^3ME
MT^L"Z/,.5T]$><=`E$>B9YUWYY1VYY-W9HS-J2[NJ9_X3#!`4J-++I>N>1=W
M%.**NP_.`WD[8PZ1W^SURU[K/`R'N-WMGE/?.!L_)0/D4R0<(*]7Y2GMFK'3
M.P@?8,_,?QE$+Q^JX^S?VQ30:(WKLXOWP*N8(/KUCP8?:AZ"Y\FQSRCOGE_5
MEDJ_O7<W\'R9.(V.HOY'/:[QY\?-.[+8HK#8!Y3KX'%-%!1UQTO;P2IN#/**
M3KX':\WIKJ`X[B.-'.?XV?\`N<6,A$OCZ2$-VO;^[_K*".S<KX.UP97ZB[V6
MV?)E8DC$X6G="O;ZNGT[T`!B\=MF1IK4XKV\=P./(Z1W3MX#6ACL79E-G1R8
M34IEG%V[Z7MFJM)I39/3-=:+$-$]<U-)-*;)Z9Z?W<><\<;F(FK=[<U8P&+Q
M\F>G]W&I/I*_8?"8CY%SZY&&`7BF&]/P(3[N2EWZCNZ6_''&=;\T4C\G;)I;
M#-&.B1:]1ZV\G36+6OAPYQ7V3;SZS)]Q"[*9P#<B:M[OA0Y+)4#T&FNQT^@7
MH2:4WKTST_NX]/[N.VSI"5>[WQG8`L7CMLST_NX]/[N.JJT0T#6^AFQ"+R.R
M=SZR*:@]OGT:?ISFS5LY'J)$\]<()]3]/]L`S1]GUT\"=QRCX1Q`HR.CD(7D
MT_5T^N=_"'??A/$+DP+[X^GC&SK@#RS(=_K-Y.V_`+X0[^$Z8FYX)VXR>$._
MA#OO_`@!\`Y7!;.!><X:63UA4)#=.6PI)DIOBP]/>%XP=H(8K+-G3Z^GU.\Y
M?JU/7P'8\;N]/`_/@X>^._#KZ8<X>`^/3UR]/`UX^^:\/1X>N//UF5UE%W3B
M"FL<-MJ\_P",\H_QGE7^,"+#0[LG8->OU]/]_P!/]_T_YQ__V@`(`0,#`3\A
M_P"?/7'G;JSXUZ9.I@NDO7[L@NH!H`#KV<ET6->Z?IG_`)O$,/W?ZKG2N>NN
MS41Q9"+2O\J7_<0ZK8+^\7[>0'ZQZPOEN'^,T\8`LM-9WS]N1)CI.+ZG;VF<
M^9R<N!]OU[&'K:/<ZW^&,E;:>W]X>`9&;#\9Y!CH;D^4X])DPZ.H<WUST>8I
MJ=Z_G0^<]H4[)R9(JW+U!DDZ?@C^,D%3EZ@R1[,L_IGD&'G9;7$.WK<AI2-P
M<`:,V'XS^5;^C\8??;DZKLYQ*T]PR"[H(&NC^OGT\&^HG#Y=/.\ZD??OX;8M
M#5U_V_IP$.1VT:3X9Y/"6DA\&#(<<'+XZ=_-&[.,>@],/5_KZ)]V_)F=X9?=
M\9BU-T>7.<B]/=+XZAQ>#E7^L]!]L1!WV_T:/MG%=_9ZGQ]`T/AV<M0G.!I^
MW^PN53$!-2DZZSMN3Y_Z)G/,`BA^%/B?XF'^RI&X3M@$FJ</Z\.(HOY<]#[6
M&;3-H:CT!?XS5(BCM8!]B_.?E?KS\G-^1^O"84FB3]8(S\+^LU-)/W+GY?\`
M6>?=L%:&)G4V3]Q/VYY'VS;PB1V1#][]S*LG7^LPTZA!^_\`!GF/5QSK!7#N
MP7Y-?YP#_:._`^1]MN;:B)[.>=]L(H>I7!KV?P_.;+)3H/1].ST]N/QW[^AY
M;V9^9_;Q_-_;'DG9XFYP)^<>E]K#=D6P!KY?XPS:$=08%^U^?H$1O/2_FWD"
MD!C%*<#C_*(.0$VR`<N3J1/ZB_`9JETO2\_HP`8^`T?XF'NW[)V9_P".>!-D
M4PYM"<,E'H%/@G,']]-XD`*B=3/ROUY^;F_,_7@-5^:[>F>9?UD3!9GY?]8)
MH0\Z9[8S&G4.7>]?C-$VCNG*^W'O^_(^V<E`/G1^<Y0K_KRZ63C>?W,.)_.>
M:]7-ZIK)VZ_?CVN`T0*%^9ZL6SPI36=+RSG&M7E3_#^PSSOMGD/1C/0]/IZO
MX^WM[QIYTO-[<?1Y;V8M$@CTVY_[>3I;*9^;^V#<`TO#&?\`MX$$O"=<!L@_
MOQ_YO'_8@?2/4_"OVOYP;1((,O>/3$@1Z#_!G.M'MYS?9V^?@_Q<U=D9S/1[
M94R47F&O'ML6,_A\"=P.DY/9CDLAQ5GH:-98K1QITW*%;)=NV_SE6M'&G3?7
M/.&/.&.\1;;_``9N)=(S^'/.&$X//:X_&!-'&45L4[.<JRMM_@RJFR]-N\GS
MSSG3DG6G5]^^5GG"\XY"E"G#TGW\=Z%:O5Z3^<J;8IV<Y0D:W^#PB,Z]"^KK
MGZ*M:..=-]<\X8\\8;;&MM['8[9V:9&<ST>V>>,>>,6UA"\YHRP:8:^/7ZO(
M^F1%[+?U/\88#WP.">D]$4_KVRSHC]K_`'@T4VY^?2Q<8"\(;[DR#8A*(:.A
MQY]?\D[^$)SO.<G;QG@`^^,Z>!O(\=<)UUC,/7ZT.GT:ZOAZ>!SB=O&=\XSC
MGG_`V`*JXT:RSA[[&(&AP1>X(<ZW>N#K43VEZ#WQ'.*Z/T/\G3%WCZGI_P"Y
M8TR'/AQ]&QZ^/7T\-?/@[</?'PZ^GT#J^/[R]/"^+/=S7SFL]'@>^>WUCR[2
M4-3U3!3)`;X&L3T??&>C[X]"-":6\BU__.W_V@`,`P$``A$#$0``$```````
M``````````````````````````````.`````````````````````````````
M`!0``````````````````````````````*`````````````````````````&
M48D0!0````````````````````````!QP/:`"``6WWH)^Y$`2.@@!*\!X!(!
M2\!M@NP!0`$WO+I,_2JXBW]7KD0!@$@`O`,9(\`*`!`Y@;H%F.9[BU.YN"`#
M?@83H!A`@`!0`%P*&53-#P?S?,.3&@+7HV^@`-7<``"`````````````````
M````````!I-``!0`*OPR^1Q,UA@IRI^V\Q1&```!<"P``*`!QQ&.6UG'$9H2
M0+1PK)$IP```,B```0``````````````````````````````*```````````
M```````````````````!0``````````````````````````````&````````
M````````````````````````````````````````````````````````````
M````````````````````/__:``@!`0,!/Q#_`.*,IKCZT:I6%&*_\8A3D<@<
M1RC2+?(#("^]S]_X(IH@#!A-S=`)BUQ`-2E+/-BH&O8%=%7F6GIKWS9J(%A$
M(Z(+MAAUT%JM2XIE"DA?XB_2DK=.*O\`<1V:5[^'!58TG#@'].5J=Y:!$P7%
M.0@"1M73+L&1RUU^=U\:`LH[?>:I!';0$'1,C&5Z=/PO/T\D5IJP_,#$6>$I
MAJZ`^A0G8#1_A2JT<CVP);*00U,;$MDT9[KEP#&&M.^135G=EGK50V/R7((B
M"#"QF[4JLJKMI.F\8HIR6A#SK:96=/#!(U0Q!C-"405N#?BL'>2354&Y`X04
MC9A7]3BZTV205MP)T=-;5(-U73&RB*QP`>+4K!4<Y/P_9VN,?RQ4VL(V`:J`
M%320,:J'[E$,Z8V)VX+-1,*LJ%7DH<]XCD@@P-V43MP-@LA=.I:2A@-8ZI=D
MW_M"*KA8&%;P6Z>-VR.0?,6/:1(B(+F;'N0T\UC"B]?"Z4EP?$&^E1P<#Y%;
M8OA(R&!8".S9W,T9V,JUU$!U.!#_`'LZ$T:+A,`01CTERI"CD8X7$>+R>=`(
M55X@MICB%9Z5\3&3G!!E<];#>&,/I":)<T%`OBN?E!Q('NQ,-3;WYFB3L+<$
M`=>,3R.+_'\W8;MG2F][@P3B'G*,53,]6VF2Q+&Z^3C*--33`GB^D^>Z8(2:
MG5WT9J*'D,?>K:"<"MO(S%#+(IW0&=!]!28/RS+0?SW;.)A+3BDC$YOXFL@,
ME/H7T4\>"=`/\(TWS6GYPK`GP]6J*\KX*Y2#8P=^?S*,*2/IP$Y3KY<%\8%`
MK&Q08%#>4HB@`ZKP!;7'XT%@^SKL!$I@"%%RP)+F1A`\94H>P"1FH;<@X#JI
MPKGQK(PLO>Y3Z>>GVO.0AYM]W/,>S-C#"?-*&LZP,L1_R2NJZH=!VCC`!1LP
M/IWI@O%O"'#L"2*R6YB"%AU1`P<"[MH@8?;SL,*GJR.6>'8:(+BL,>O%8TE&
M4MSAQ!'#MK&FA"+.6E-(`7"#)531WX*^8$*&/:SEHQP[)7/WLB?("=<S?J]/
MON_P5NL'_K/T:<:+PB\<10%!17``&@'4H:>Q^_XPPNFP9M9V#R@9-)OKYU*,
M")"#Q7#4U-A,S&LS"\)@D7ZABG,M0)BF&/PB/VF?EB>0&;A_]HT16[YDX][^
M]"B$#M'5<BO`RI58&E_PC7>M.#?]7.+``&MA$JFO457#>';(E98!%`F\`"!#
M#1%U4\E:;2#KA";VM[-\HWP/#(TP$]M""('DZ:>.5-\`HP'F?R]C/UKVP^V\
M_P!,/5Y_IO;8U`D,91<1$H)U'AO`3V0"<%C9P@20^YRZM:/JU)S@NIID4Z"Y
M6PNCXH$&4Y*I]"Q,0'!ZX"RFP#PR"<HTO.!$G^34CTQVD`[E=12+ME%A0[Y6
MT3ND_&97HK%#!JI.=8#-W[I7^Z%')"1I3/3K5=(A$<>^3V>O=F@+X=]5Z>W,
M5U6MCOWCWQ!5B:$45/,J<\_I+X->4&!6:JO>L4ZB_$(`)X)+Y_,!VIA!`E"!
M4S_OQ?HCDYA6W>I(CX:#5(X:L5QBUTL*:+RC.C1X'53#"TE=!M-MZXTAE136
M(((D1!P`0(5?E57W5^C,"-&V#0);-HC>[`5L@$I9DOL=V4&^0L12=H8.$:RH
M5E(?,#Z/\;A8Y;S:H\KD%9J,Q6Q4<MN=,E9CCQLI&7N1N4SF`2^$Q+S*J@+>
MA;8%Q>X<]DS]"X0X.O55[;K946XR&Y,$31DM%M+A#.?,L2JBV93G)^:Z^'B@
M:6V."-0G:Y)CIN`>.T="397C)\8`TT(D_P!+V6NKN<!16+J/74A```8UQ&G#
MV,;%LK#]C3)\/^^$IJXDU,HCI(9,W-,5,C&&RNN:'43%V<=;7=#"$A-8N[BX
M0LWV%S88)*$6:@G2(#L8`CW'[-CW'A.ID?\`Z:$:00_19"7O)QR:C6)=6+7*
MKPJXFIU+R@E$J42G)>IZF1*H0GG(=W0(AUFTN8`+ZP\8_GW.]E:);RG.2(#[
M!]IX0QOHX<S;NTA:KH6IV_:EDH4):V9Y%\CP#)65NZ'(`D]6]F@"ZT3DQST0
M`EPB'`!]@'X/I[Z0[K\F,GJQ@@X[729SR;K!4M-;73KEYP6'\)6E-!BAFQVA
MX9RHQ`1=8?[L+_WOID[`=C&MM)5>0]C'U57501=O`XHMK44XY8Q[1AA#'"G/
M!+JW&_XV%C9MXX)?QAY:-HF4)5J`0#$0#/=CX8!&1IB@GAU'P<2T/E*3\WDB
M%%744L(%"C;B.^-%B&,#VY*$>732`3SNMF/!P)U6!&I"Q86`T'/>Q=;HM)F\
M+:'$A@'2`+JBO85">L4!(F\9*D-6X%9RL/<!B3Q%A9/G@"!!8>!/&[)S35$.
M<RUF#1>DO1K*2-,7X3SZO([!4OX`?2+IIW-;$/@1ZF@#ZQVR*SG22U"$*=X"
M7R;4ZV7%^$*PN2^#JA[Z&"\H)IR)0`B+GS]SHN&5=A>_FP,-$C-?+5M4061H
M/?STN![_`-,WN=2,0J$S?M^@:'GN&8<4T6@S`+"5,#+7#R(,VO&6X/"*51H0
M[BBR+)9[F_\`^,Z;57;N6W\@R35&AI*X3Z;JUAO%4T3BUE-^<@VV(I;?KU7N
M>6X<S`XSH]-`,;N.=YC;V8RJ``;2"ML22)2>1<.@%48@B1D/K'0MHHH`4%)B
M0^8F"-$X!P,<L'\A&=B9TQ8,H;CIT.\R;@`Q_,6?LDM%0HFF?XQH,#96!J6E
M;>`3!/)JB'`C<;3FL;HZK(#?Q1R@69BN=>J0YV1/8AM\/#0IF)31=C](HO;!
M)$C,/\0K.-)9#/*+E>^"6,8:GNO02@*TL$;F@#EA7"YD`;87VIFR;=<)"7FG
MN+7KE5@LY982#4I6D7!W+22%2YI:^0IOR*?N:&7T`0*7UV)+/TL)V89$+L)T
M4`H%4/;%BB([G?`1-5A"Y[T,D)%YI4C.SR@CRW5F!$C(^:2L'GR,<"AVDC/9
MSN&"R*^N:#5E`U.&N#ZJ7J00WH>YV>B4(P(L*F>J\+Z/4B#1Y(QJH4BE3LNT
M\:FF`#(DT@D[#NZ6J,NKV`O`4#,-L)RX1VDHNF[(';QR>"0FO2;<9&L1-M(U
M*!@'A-0(%;U^(*]VZGHS?0JTXQG(Y,K@EQ3(PT>+V<W@XEM9-"BY/(TD?U<W
M27=9KJC8&'^U<&#`NA@DPG?-0&`99&__`()L#)/7>V/J:BNP(MT-&O7!4@V>
MK12Y(RO.!_+[S_=P#?->/2Y/1B)8CIB.0/,-_P#D2M"C7("9RHNY?@70_P",
M?__:``@!`@,!/Q#_`.*FK_OSE_OSE_M#]45TN"@B!"G,CI<466"*4KDD"[KU
MPLFH(=A!-`-Q+MF/=H,D*L-M`#<5O@Q)K!X^4HOSC^)MPL+*CU4YZE,;4#9L
M#T*]9O?T=7^TND^)J&DZ4&>F$TQ$I"E=,U[9'7TIM%UT!3R=EZN2[!,CF-GS
MBXU#>;?S^N'+K,9A3E$$')N.F<X>C`RS7=*!5AX7#:R++9H+Z*#Z#E]-U^;R
MA;.>#GC$5E?5$2<A'-FLOF=8%*FH+)<:XQ%5N%!FATV/+\9?'2&V\4.K:`J)
M3*8#1@B(!!CQ1B;@2O.+&N1%=0;Y,15:$=W!MJOMC^JPUFT-\F\UEKO56.D1
MGOX57!::+L%`\"G&\O/Z>5!LVZ,8PV\AR.!T,*S!ZG(ZH]###--AOP1X?D6G
MHI+!R-,#$X?7!GN$QLC?"&J;:ZLZXCDPYL@T.K`]2P"$1I0`.UV[?"I[J5I.
M1O;>&_4QQ)1I-E.Y(Z$)V8'H.JE(Q-CZX8I2L0-VG<Z5VY$=`Y`B(Q$=B.D>
M'$!+!,`(&]KO`"#B^+L*`CK[#U..N#`[C.!*]%='3Q.[JNE56<\/;"$096@0
M7JPYZ^+J$"5Q([5WFZ<<06@TD'"B0/43;L:QQ32)!"D-0V3HTZ>,8%M`92E4
MZ8[[?+@]YG^B+BR535ELN\>/'DT@H52P(0`@8@8+![*H_9>^)YL\P#MD0>XY
M'Z#E]4W1D'^V["66%YF!#2>"TBU+.8SMB3(-0EXH2_?PDC+`B=9"(*NE(;,$
MC@44H"<@I?\`M]$&RZX:5@'/?<WCAWR79]N?1%Q-NI6665G?PS>7]\(?@2<)
M1.%&E41B9QI@&N%1^Z=O0SR#LQ*19G+9>M`'88ZR[&HAZTA>A3O=)SDR,KMW
M@Z$OO`[^"!L1*<H`'JJ!CD.2VZ8O1:<5."SI,$4"<L3ET=Y@+P]]4OBFO"H7
MJ+UB$=NWL.H$?KSZR,T]`4R[/%QTF!R>_P!9*1'G.?H8N-Q'NCC;$RM((W1(
M`VR-9Q,UKP\EIB<@@>&IKZ*1D@`5%[1R<=OY$$Q/""NJ!G>/;.C0]Y!"8(*;
M<)7JK02*PQ0NA1Q_B-"-NT/%??%SGMU>P=`.``!H/H.7U#2XPP!`X`(`Z'0Q
M(I$;\$DZ+B=$DGJ8>,H%B-B,5PCI,F!N+AM-"?JO4`F&H:Z*(B>:;->$&2/A
M+JW,H*316[9TWG4Q+DJV`$JZ`C6WP[![AIB-.RE.X3!.`-T`9-`X*0%01,1!
MW&M1_<E#N!W0\H[,A&NH\*X]%'O@[1:04CVH8O%H\&!+\B#WPLG+7KGD';'$
M&&N.P^YN<F-T9XB)NKHE@1=DP?+D,$;=Z;=,Z&<:-J-`3\H[K>?!II+F\QX=
M'<NBX"V@+T+1.$AH$@0-`00-)`5SD]_H!0XP<4S%$$X]L]1BA?38"6JQRCFZ
MRM?D<,$D%5A$I1&()USU&!WYDZH.:D01'AQGT"CVFW$=$/+UQ(1D15R)8CU'
MZ20)R$!&B<D>O0LO7`7EL"(@L78LZX3-!K8V@N84`LRG6V\O04&006IL7Z3E
M\?2+:J/JU-(<MYSB2!I2K%85T5\0C3NE0D-4$TQ\-/B48MH>I;-"G#EM>&)/
M(6@.PP#P93$*I!E05PZWSFF$E$"$%Z`N\N!!4@RH/0ZWSX8?1P0U*:YI/:C5
MWK6`DZWF*DD&OKX(=T_RFWW?<#K<6NJ5*JEJJ[5>7KG$P96BE*4[E,+\#%I%
M=CLJ[N.%G2@14:P!@X:8[!+<*`NA+I&Y`*Z?8@:%8:[N/U-JUZ;F(0X@#3B)
ML7!F#``!CP='XQ&PO=SCYDMA2E*>E,)$KIFEL-&O-X\.)?@1(ZT>=@EG*8M:
M\^.A::D#5!Z.-^*%*68`;R;`[*MWXPF497-J:0Y;;XH4)8$@$C!)C3=M:]<+
MI-:4)1"D":Q:WZB6_O0-(F5IZ\>SJ*I]OS8+Z);H4[X:=@)QD(E&O5#4^*_=
M^HY?[48%JD'$H=$FE^_69<;LP"#1@2HX%A4-75R2_'WI>;9%`-@L3Z3E])MG
M7$C'`6*8D9TP8L>B.3<Q&HEP%XZ8%XQ.'E[9P7M@#GV1P`Q4^3]YTP*S(4,?
MQ`7]8@:I]G`%!8>?WB1G)X35S?3?@*CH^^)K<'O\\]O!%#G$C,(5A]G$F5>[
M`(-/D^-]N,"Y!:$=?^N<**L+YUC++FH6%.(XDSFH.S?^`,\1ZCH'[Z!MT.,E
M5EVQA@@/(8-&'8HX54TKANQQ][:HP0B0*C2Q)@_9)8MT*PNYKZSE]*ZAS?QV
MQ5<4HLUV_&L$$3ID9M*K\=O/?!Z=\X:/GSO#UPA=5)_/3SZY<`ZAGXP8W.N.
MR/9G7YQ`-]CX*NN,Z)"/7@\^V*KKXUASEFF_+VO]8@Y8IQ+E@OI@2HCY\_UX
M5B'/?#=J1^?WQC20SOK&7613UP8W.OIBT=*,/6[O\;WTXP$18WXQAK\YH&BA
MU!_C'OYYP@H]#?;T[>^EQ"DT?6\I)K1NE`0[)2CIQ+GD62U7K5:O5\(+@FWY
MD>@#B(:05N`%^HY?[\Y?[_J_W]U/^,O_V@`(`0,#`3\0_P#BNO\`O^O^_P"O
M^T,C!CK/(.*A#U-Y,KJ#82D(T@TFC3P<9602QH-*G85];E;VR9`@:-U<4DR-
ML<8AJ>$AUV.GL.!R=`P3/C30Z]G#^KF0%*[GJ(TZ?1U_V@J-@)'B@'>"T2*%
M)PH*>F)N;9[:NI]GE\@"=A1506J@;E[06A`Q\</(\2/'*=SA;MK2][P*I3IW
M!QQ,N#I:@5HNJGF`[5,"J["Z@E'2[UZ?1U^E7B#`V,\CW?CM@&S-(`C[AIA;
M8\WIE+TZ`0!U2;MT7J#K+[^&BI!P>QVS9T_;%A*"^^6K.$-WICE(0VK:B(PL
M>'J(PQ2`80)$-(ECJF.>A6`$/T0X'3'6`A`D0TTX<#K(!)27GU9Z3S>F;0["
M!TCT<AP.NO..68D'0"2CZWXP7X3:A1/48D\Z%^4@VG*7VIE%NITU13%C$3N(
M^F1!*`4H2G7C`)IN!26P**4;X.JN)'&)#U(VN*&G25TQ;!T@A:.#7`>`[\$C
M2)PCN$UQZ&"S3`!2"@A47J*=2Y-E:"E1V?&;NL`!1TL%]A0V<3``044>Y@=I
MENPC=BS30G7OI\6A!1032M-.'MD6JF0"@:``-=O%^0;2<(.1Z+\=L0<8:0C4
M.A7Q1%'A1@NT>R<8CY+\8XJ:V!G0J-RE2ETS%$NX=1TOJM7J1Z^/X']8-2;>
MC>E7CXGO@7?)^+.PP5EM%Z62YK+_`*BWRE$-MC>6X>H76CD"ZEH=NIZZ*Q+$
M$'"T6#3R7K]'7Z5Y3KEHED`(TA4%-;PA(`L16>"@*!3F#,Q(K/)6TF(0)0JL
M*Z=+=&*IH(D(#$8H2BAW]%%<=FM;-M(13TW@3DN'MP/;(1=666&>2=F>4]F`
MA11U$[\B<B;'9B&V<+8C]VBZ9Y]WXYEEK)W#B0O%#M1.JM>)*^>I-1HS>7=[
M_#5FZM0]`V'4-T]."#"R/0"KKL99$7A`$IU%006IP')P1PI=(E)N5Y,\.(O6
M6FA3C7#GFW?FUHD3JUOH:]SB'896LNNQY:\B=&]\!IY_QVL!E5<)5!Z9-<HK
M]E*!4D55TW0ZN;`CJP("$4U=`#NAX?B?UA666Y!S1$UZ<=\J;EE0`.P"+[Y#
M9[A*4/("\&JH9#ITV-@"E-\7:II,W#[M4="-)I:>Q@A9@P#T#_UZ_1U^GR3O
MEFQ*O,M%UM>KU=X"TL>;CP/`@(E$K3EYA*`Q)I"CV39TQ=H^QY*MI/01H.1@
M"[UJ)L1\O?Z+.Z[8\E*)H5%V<O\`V<\_J`("!J(=$SR3LPAZ).`HI&NN\1RB
M"D(8E('I;W3G`X$VD5D71(!['H#CS[OS7];=J%UX`_&#:P2=IN$73`!-Y<>V
M@%@5*ZFE,ZR5><_%X+M=M!#UJ<=`B\ACM]P=10,*"ZLKE8I(X%H0K@V5ZX_$
M5L:1=.P8.D"!'/-N_P`-"J%TH0&+%O1ZW$R."#W[A&2',M-.X`\8\_1:0^PR
M*XDF?^T_K'U["T&#/>(_)FJY+;L0J`(ZY$WG_H/ZR_!^4`49\B8.`(1V)Q8W
M\C]L-A#1&B-$UR.QZ/T?@/UD-X%YOE00^SWF,??9((JG+H:ZZ<;2Q-%DH)1G
M)::==>;0D(%`H\#:P!#ZCK].S8*+N+>PXF<TQ%805A6&]'CP=C6&F[J?9/!0
M%:`[PD!ZDZ#R"&VA0;/<(=4[J]7-Z%39H!%$Y"ZXS:UU7DG4`Y4UQFPCILH0
MB@Y"ZST,+T,)-N%K*H#LT0.F;=)A*I-WL>F>AA2-75_T:]]L`<`X.AZ'IG*Z
M)1A&.XSTQ]L1R50.@2!TPK.B+H`')M#Y&>LM,H`;02+IG6R<6*NT`Z]C-:;1
M(=`F@[8=JHEPT3P%M*@/5#9.QZ.Q.042C",8QGHYTH>I634T?'SX$X&4ZSC;
MO1:,G8^C9!$V%`(H.3MGH5C]/+WD`Y*IT`D'3-_!=+D3;V';/3RO3R^MZ*&*
MNT`Z]C->>DX)2BGJL3\?5^`Q4!H^ATKJ_.GW##X_`S'DA:548]Y4Y2=<%"LK
MTT7MT-]9OI]77_:_@?UA+$]<=+6K[)M,HCH1/O>W3$S`*O`N%FY7>*JMICJQ
MM["->H4^IU^D,XUUS7E*9&SKAO(.R/[XP.CSZXCJ'`7XQIP7!/&>O3.H;/$<
M`8J>T_>4XZX*EF(.F`^?V+^L`T-?9_G`*5!]]8Z?"//3-].<1.<!<`[T]D_?
M@%9B1F`BP9V<29&QMR/#S@&%`[_^8!M">>^!JJ2S(R],!U3MU_7'_>)U=L2.
MBN/\#.D(0`ZOFKHW@[HD*2&Q)LX?7C(B8"W0,![2)ITR]&!552$<0#L.=8FT
MP&,6#RZCQ>'Z^OTW@2W?]9349#VIK\]I\Y6'50\'.D=(<SGH7"/H/ZRMJ'0Y
M7^/G"</'GR]S7#CU#OI/?K?OBH:W_P"XFN?/_6#C0/)/Q<WTT^%J7X]OG_K#
MUP8;>S^O!B)@$-!O6P]>OZZ8JW^)^#PO*>ST]9BQIQ@S+!?3"Z@IQ[_?P.'B
M^>F+0O#S^,=B'\=UQG3*H]9//FX:;ASA`-%.FIMYT5\W6`CF5\3SZ8P0YN*`
MTH=0>_<Q],35CY+8=*/MTQEY3U^N5\Q:I14#%LO.Y0PVT:I``7GHYST\CT\A
<8,>"!0$!%73`YKQ]77_?]?\`?]?]_P!?^,O_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
